<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.1 20151215//EN"  "JATS-archivearticle1.dtd"><article article-type="research-article" dtd-version="1.1" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:xlink="http://www.w3.org/1999/xlink"><front><journal-meta><journal-id journal-id-type="nlm-ta">elife</journal-id><journal-id journal-id-type="publisher-id">eLife</journal-id><journal-title-group><journal-title>eLife</journal-title></journal-title-group><issn pub-type="epub" publication-format="electronic">2050-084X</issn><publisher><publisher-name>eLife Sciences Publications, Ltd</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">58597</article-id><article-id pub-id-type="doi">10.7554/eLife.58597</article-id><article-categories><subj-group subj-group-type="display-channel"><subject>Tools and Resources</subject></subj-group><subj-group subj-group-type="heading"><subject>Immunology and Inflammation</subject></subj-group></article-categories><title-group><article-title>The leukocyte non-coding RNA landscape in critically ill patients with sepsis</article-title></title-group><contrib-group><contrib contrib-type="author" corresp="yes" id="author-186643"><name><surname>Scicluna</surname><given-names>Brendon P</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0003-2826-0341</contrib-id><email>b.scicluna@amc.uva.nl</email><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="fn" rid="con1"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-191110"><name><surname>Uhel</surname><given-names>Fabrice</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">http://orcid.org/0000-0003-4946-8184</contrib-id><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="con2"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-191111"><name><surname>van Vught</surname><given-names>Lonneke A</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="con3"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-191112"><name><surname>Wiewel</surname><given-names>Maryse A</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="con4"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-191113"><name><surname>Hoogendijk</surname><given-names>Arie J</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="con5"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-191114"><name><surname>Baessman</surname><given-names>Ingelore</given-names></name><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="fn" rid="con6"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-191115"><name><surname>Franitza</surname><given-names>Marek</given-names></name><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="fn" rid="con7"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-191116"><name><surname>Nürnberg</surname><given-names>Peter</given-names></name><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="aff" rid="aff4">4</xref><xref ref-type="fn" rid="con8"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-191117"><name><surname>Horn</surname><given-names>Janneke</given-names></name><xref ref-type="aff" rid="aff5">5</xref><xref ref-type="fn" rid="con9"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-191118"><name><surname>Cremer</surname><given-names>Olaf L</given-names></name><xref ref-type="aff" rid="aff6">6</xref><xref ref-type="fn" rid="con10"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-105980"><name><surname>Bonten</surname><given-names>Marc J</given-names></name><xref ref-type="aff" rid="aff7">7</xref><xref ref-type="aff" rid="aff8">8</xref><xref ref-type="other" rid="fund1"/><xref ref-type="other" rid="fund3"/><xref ref-type="other" rid="fund4"/><xref ref-type="fn" rid="con11"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-191120"><name><surname>Schultz</surname><given-names>Marcus J</given-names></name><xref ref-type="aff" rid="aff5">5</xref><xref ref-type="fn" rid="con12"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-191121"><name><surname>van der Poll</surname><given-names>Tom</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="aff" rid="aff9">9</xref><xref ref-type="other" rid="fund2"/><xref ref-type="fn" rid="con13"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author"><collab>Molecular Diagnosis and Risk Stratification in Sepsis (MARS) consortium</collab><xref ref-type="fn" rid="con14"/><xref ref-type="fn" rid="conf1"/></contrib><aff id="aff1"><label>1</label><institution>Amsterdam UMC, University of Amsterdam, Center for Experimental Molecular Medicine, Amsterdam Infection &amp; Immunity</institution><addr-line><named-content content-type="city">Amsterdam</named-content></addr-line><country>Netherlands</country></aff><aff id="aff2"><label>2</label><institution>Amsterdam UMC, University of Amsterdam, Department of Clinical Epidemiology, Biostatistics and Bioinformatics</institution><addr-line><named-content content-type="city">Amsterdam</named-content></addr-line><country>Netherlands</country></aff><aff id="aff3"><label>3</label><institution>Cologne Center for Genomics, University of Cologne</institution><addr-line><named-content content-type="city">Cologne</named-content></addr-line><country>Germany</country></aff><aff id="aff4"><label>4</label><institution>Center for Molecular Medicine Cologne, University of Cologne</institution><addr-line><named-content content-type="city">Cologne</named-content></addr-line><country>Germany</country></aff><aff id="aff5"><label>5</label><institution>Amsterdam UMC, University of Amsterdam, Department of Intensive Care Medicine</institution><addr-line><named-content content-type="city">Amsterdam</named-content></addr-line><country>Netherlands</country></aff><aff id="aff6"><label>6</label><institution>Department of Intensive Care, University Medical Center Utrecht</institution><addr-line><named-content content-type="city">Utrecht</named-content></addr-line><country>Netherlands</country></aff><aff id="aff7"><label>7</label><institution>Department of Medical Microbiology, University Medical Center Utrecht</institution><addr-line><named-content content-type="city">Utrecht</named-content></addr-line><country>Netherlands</country></aff><aff id="aff8"><label>8</label><institution>Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht</institution><addr-line><named-content content-type="city">Utrecht</named-content></addr-line><country>Netherlands</country></aff><aff id="aff9"><label>9</label><institution>Amsterdam UMC, University of Amsterdam, Division of Infectious Diseases</institution><addr-line><named-content content-type="city">Amsterdam</named-content></addr-line><country>Netherlands</country></aff></contrib-group><contrib-group content-type="section"><contrib contrib-type="editor"><name><surname>Giamarellos-Bourboulis</surname><given-names>Evangelos J</given-names></name><role>Reviewing Editor</role><aff><institution>Attikon University Hospital</institution><country>Greece</country></aff></contrib><contrib contrib-type="senior_editor"><name><surname>van der Meer</surname><given-names>Jos WM</given-names></name><role>Senior Editor</role><aff><institution>Radboud University Medical Centre</institution><country>Netherlands</country></aff></contrib></contrib-group><pub-date date-type="publication" publication-format="electronic"><day>11</day><month>12</month><year>2020</year></pub-date><pub-date pub-type="collection"><year>2020</year></pub-date><volume>9</volume><elocation-id>e58597</elocation-id><history><date date-type="received" iso-8601-date="2020-05-05"><day>05</day><month>05</month><year>2020</year></date><date date-type="accepted" iso-8601-date="2020-12-10"><day>10</day><month>12</month><year>2020</year></date></history><permissions><copyright-statement>© 2020, Scicluna et al</copyright-statement><copyright-year>2020</copyright-year><copyright-holder>Scicluna et al</copyright-holder><ali:free_to_read/><license xlink:href="http://creativecommons.org/licenses/by/4.0/"><ali:license_ref>http://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p>This article is distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link>, which permits unrestricted use and redistribution provided that the original author and source are credited.</license-p></license></permissions><self-uri content-type="pdf" xlink:href="elife-58597-v2.pdf"/><abstract><p>The extent of non-coding RNA alterations in patients with sepsis and their relationship to clinical characteristics, soluble mediators of the host response to infection, as well as an advocated in vivo model of acute systemic inflammation is unknown. Here we obtained whole blood from 156 patients with sepsis and 82 healthy subjects among whom eight were challenged with lipopolysaccharide in a clinically controlled setting (human endotoxemia). Via next-generation microarray analysis of leukocyte RNA we found that long non-coding RNA and, to a lesser extent, small non-coding RNA were significantly altered in sepsis relative to health. Long non-coding RNA expression, but not small non-coding RNA, was largely recapitulated in human endotoxemia. Integrating RNA profiles and plasma protein levels revealed known as well as previously unobserved pathways, including non-sensory olfactory receptor activity. We provide a benchmark dissection of the blood leukocyte ‘regulome’ that can facilitate prioritization of future functional studies.</p></abstract><kwd-group kwd-group-type="author-keywords"><kwd>non-coding RNA</kwd><kwd>sepsis</kwd><kwd>leukocyte</kwd></kwd-group><kwd-group kwd-group-type="research-organism"><title>Research organism</title><kwd>Human</kwd></kwd-group><funding-group><award-group id="fund1"><funding-source><institution-wrap><institution>Innovative Medicines Initiative Joint Undertaking</institution></institution-wrap></funding-source><award-id>115523</award-id><principal-award-recipient><name><surname>Bonten</surname><given-names>Marc J</given-names></name></principal-award-recipient></award-group><award-group id="fund3"><funding-source><institution-wrap><institution>Innovative Medicines Initiative Joint Undertaking</institution></institution-wrap></funding-source><award-id>115620</award-id><principal-award-recipient><name><surname>Bonten</surname><given-names>Marc J</given-names></name></principal-award-recipient></award-group><award-group id="fund4"><funding-source><institution-wrap><institution>Innovative Medicines Initiative Joint Undertaking</institution></institution-wrap></funding-source><award-id>115737</award-id><principal-award-recipient><name><surname>Bonten</surname><given-names>Marc J</given-names></name></principal-award-recipient></award-group><award-group id="fund2"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100006020</institution-id><institution>Center for Translational Molecular Medicine</institution></institution-wrap></funding-source><award-id>04I-201</award-id><principal-award-recipient><name><surname>van der Poll</surname><given-names>Tom</given-names></name></principal-award-recipient></award-group><funding-statement>The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.</funding-statement></funding-group><custom-meta-group><custom-meta specific-use="meta-only"><meta-name>Author impact statement</meta-name><meta-value>Long non-coding RNA profiles as a source of signal in sepsis.</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec id="s1" sec-type="intro"><title>Introduction</title><p>Sepsis is a multifaceted syndrome that develops as the consequence of an abnormal host response to infection leading to organ failure and high risk of death (<xref ref-type="bibr" rid="bib1">Angus and van der Poll, 2013</xref>; <xref ref-type="bibr" rid="bib16">Cecconi et al., 2018</xref>). It is estimated that 2–5 million deaths worldwide are attributable to sepsis (<xref ref-type="bibr" rid="bib27">Fleischmann et al., 2016</xref>). Despite empirical antimicrobial therapy and advances in intensive care, it is expected that sepsis will remain a major healthcare problem. As such, sepsis has been recognized as a global health priority in 2017 by the World Health Assembly and WHO (<xref ref-type="bibr" rid="bib71">World Health Organization, 2017</xref>). In spite of more than 100 clinical trials having evaluated drugs targeting specific components of the host response to infection (<xref ref-type="bibr" rid="bib42">Marshall, 2014</xref>), no specific treatment for sepsis has been approved (<xref ref-type="bibr" rid="bib1">Angus and van der Poll, 2013</xref>; <xref ref-type="bibr" rid="bib16">Cecconi et al., 2018</xref>). This argues for a deeper understanding of sepsis immunopathology to identify veritable drug targets (<xref ref-type="bibr" rid="bib42">Marshall, 2014</xref>; <xref ref-type="bibr" rid="bib64">Tse, 2013</xref>).</p><p>Protein-coding RNA expression profiling of blood leukocytes from sepsis patients has helped to broaden our understanding of sepsis immunopathology (<xref ref-type="bibr" rid="bib65">van der Poll et al., 2017</xref>), for example, by unmasking defects in leukocyte energy metabolism of sepsis patients (<xref ref-type="bibr" rid="bib17">Cheng et al., 2016</xref>), and by classifying sepsis patients as transcriptomic endotypes with prognostic and pathophysiological value (<xref ref-type="bibr" rid="bib57">Scicluna et al., 2017</xref>; <xref ref-type="bibr" rid="bib18">Davenport et al., 2016</xref>; <xref ref-type="bibr" rid="bib70">Wong et al., 2009</xref>). From fruit flies to man, the protein-coding part of genomes from different species is remarkably similar in numbers and functions (<xref ref-type="bibr" rid="bib39">Liu et al., 2013</xref>), which suggests that numerous aspects of complex biology in eukaryotes might stem from non-protein-coding regions of the genome. The increase in genomic coverage of tiled microarrays and massive cDNA sequencing undertaken by the Functional Annotation of the Mammalian genome (FANTOM) consortium revealed pervasive transcription outside of the known gene loci (<xref ref-type="bibr" rid="bib32">Kapranov et al., 2002</xref>; <xref ref-type="bibr" rid="bib12">Carninci et al., 2005</xref>). Moreover, such studies facilitated the demonstration that non-coding RNAs were under negative evolutionary selection, which implied functionality rather than plain ‘transcriptional noise’ (<xref ref-type="bibr" rid="bib49">Ponjavic et al., 2007</xref>). Indeed, a substantial proportion of non-coding RNA, by general convention defined as long (&gt;200 nucleotides) or small (&lt;200 nucleotides) non-coding RNAs, yields clear phenotypic effects in both in vitro and in vivo functional studies (<xref ref-type="bibr" rid="bib74">Zhu et al., 2016</xref>; <xref ref-type="bibr" rid="bib28">Gebert and MacRae, 2019</xref>; <xref ref-type="bibr" rid="bib3">Atianand et al., 2016</xref>; <xref ref-type="bibr" rid="bib13">Carpenter et al., 2013</xref>). Ever-growing numbers of small non-coding RNAs, for example micro (mi)RNAs (20–24 nucleotides), or long non-coding RNAs such as long intergenic non-coding (linc)RNAs, have been linked to human diseases (<xref ref-type="bibr" rid="bib5">Bao et al., 2019</xref>; <xref ref-type="bibr" rid="bib24">Esteller, 2011</xref>). An important aspect of non-coding RNAs is their capacity for precise regulation of cellular biological processes via epigenetic mechanisms, including complex immune system processes (<xref ref-type="bibr" rid="bib14">Carpenter, 2018</xref>; <xref ref-type="bibr" rid="bib4">Atianand and Fitzgerald, 2014</xref>; <xref ref-type="bibr" rid="bib45">Mehta and Baltimore, 2016</xref>).</p><p>Knowledge of the non-coding RNA landscape in patients with sepsis is limited. Here we report a comprehensive screen of non-coding RNA expression patterns in blood leukocytes of patients with sepsis and their relation to clinical characteristics and soluble mediators of the host response. In addition, by using a guilt-by-association approach we positioned non-coding RNAs in network modules encompassing protein-coding RNA reflecting distinct cellular biological pathways.</p></sec><sec id="s2" sec-type="results"><title>Results</title><sec id="s2-1"><title>Protein-coding and non-coding blood transcriptomes</title><p>In order to build a comprehensive map of RNA expression in the context of sepsis, we evaluated protein-coding, long and small non-coding RNA expression in whole blood leukocytes from 156 sepsis patients and 82 healthy subjects (median age (Q1–Q3), 54 (42 – 60); 26% male). Patient characteristics are tabulated in <xref ref-type="table" rid="table1">Table 1</xref>, causative pathogens in <xref ref-type="supplementary-material" rid="supp1">Supplementary file 1</xref>. Principal component (PC) analysis of the most abundant protein-coding RNAs (n = 18,063) and long non-coding RNAs (n = 16,087) showed clear partitioning of patients with sepsis distinct from healthy subjects (<xref ref-type="fig" rid="fig1">Figure 1A</xref>). In contrast, small non-coding RNAs (n = 4949) showed only minimal separation between patients and healthy subjects. We observed similar patterns after calculating the molecular distance to health (MDTH)(<xref ref-type="bibr" rid="bib9">Berry et al., 2010</xref>; <xref ref-type="bibr" rid="bib22">Dunning et al., 2018</xref>) index, a measure of transcript-level expression perturbation relative to health, with significantly higher MDTH indices in sepsis (<xref ref-type="fig" rid="fig1">Figure 1B</xref>). Notably, long non-coding RNA transcripts exhibited the broadest expression perturbations in healthy participants and sepsis patients, exemplified by the highest overall MDTH indices (<xref ref-type="fig" rid="fig1">Figure 1B</xref>).</p><table-wrap id="table1" position="float"><label>Table 1.</label><caption><title>Baseline characteristics and outcomes of critically ill patients with sepsis.</title><p><supplementary-material id="table1sdata1"><label>Table 1—source data 1.</label><caption><title>Baseline characteristics and outcomes of critically ill patients with sepsis.</title></caption><media mime-subtype="plain" mimetype="text" xlink:href="elife-58597-table1-data1-v2.txt"/></supplementary-material></p></caption><table frame="hsides" rules="groups"><thead><tr><th>Parameter</th><th>Sepsis patients <break/>(n = 156)</th></tr></thead><tbody><tr><td valign="top">Age, years</td><td valign="bottom">62 (50 - 70)</td></tr><tr><td valign="top">Male sex</td><td valign="bottom">98 (62.8)</td></tr><tr><td valign="top">White ethnicity</td><td valign="bottom">140 (89.7)</td></tr><tr><td valign="top">Medical admission</td><td valign="bottom">117 (75.0)</td></tr><tr><td valign="top">Immune suppression</td><td valign="bottom">45 (28.8)</td></tr><tr><td valign="top">Cardiovascular insufficiency</td><td valign="bottom">43 (27.6)</td></tr><tr><td valign="top">Malignancy</td><td valign="bottom">45 (28.8)</td></tr><tr><td valign="top">Renal insufficiency</td><td valign="bottom">18 (11.5)</td></tr><tr><td valign="top">Respiratory insufficiency</td><td valign="bottom">37 (23.7)</td></tr><tr><td valign="top">Charlson comorbidity index</td><td valign="bottom">4 (2 - 6)</td></tr><tr><td valign="top">APACHE IV score</td><td valign="bottom">72 [58 - 92]</td></tr><tr><td valign="top">SOFA score</td><td valign="bottom">7 (4 - 9)</td></tr><tr><td valign="top">Shock</td><td valign="top">86 (55.1)</td></tr><tr><td valign="top">Mechanical ventilation</td><td valign="bottom">128 (82.1)</td></tr><tr><td valign="top"><italic>Primary diagnosis</italic></td><td/></tr><tr><td valign="top">Pneumonia</td><td>99 (63.5)</td></tr><tr><td valign="top">Community-acquired</td><td>68 (43.6)</td></tr><tr><td valign="top">Hospital-acquired</td><td>31 (19.9)</td></tr><tr><td valign="top">Abdominal sepsis</td><td>57 (36.5)</td></tr><tr><td valign="top"><italic>Outcome</italic></td><td valign="bottom"/></tr><tr><td valign="top">28-day mortality</td><td valign="bottom">48 (30.8)</td></tr><tr><td valign="top">90-day mortality</td><td valign="bottom">59 (37.8)</td></tr><tr><td valign="top">1-year mortality</td><td valign="bottom">77 (49.4)</td></tr></tbody></table><table-wrap-foot><fn><p>Data presented as median [Q1–Q3], or n (%).</p><p>Abbreviations: APACHE, Acute Physiology and Chronic Health Evaluation; ICU, Intensive care unit; GI, gastrointestinal; SOFA, Sequential Organ Failure Assessment.</p></fn></table-wrap-foot></table-wrap><fig-group><fig id="fig1" position="float"><label>Figure 1.</label><caption><title>Coding and non-coding RNA expression in leukocytes of sepsis patients and healthy individuals.</title><p>(<bold>A</bold>) Principal component (PC) plot depicting PC1 and PC2, and (<bold>B</bold>) the molecular distance to health (MDTH) index of protein-coding (n = 18,063), long non-coding (n = 16,087), and small non-coding RNAs (n = 4949) in healthy subjects and sepsis patients. **p&lt;0.01; ***p&lt;0.001. (<bold>C</bold>) Volcano plot representation of differences in coding and non-coding RNA expression between sepsis patients and healthy subjects. Horizontal (black) line denotes −log10 transformed adjusted p-value of 0.01. (<bold>D</bold>) Pie chart showing the subclass distribution of significant long non-coding RNA (adjusted p&lt;0.01). LincRNA, long intergenic non-coding RNA; rRNA, ribosomal RNA; TEC, to be experimentally confirmed; Mt tRNA, mitochondrial transfer RNA; Mt rRNA, mitochondrial ribosomal RNA. (<bold>E</bold>) Pie chart showing the subclass distribution of significant small non-coding RNA (adjusted p&lt;0.01). miRNA, microRNA; snoRNA, small nucleolar RNA; C/D box snoRNA, C/D box small nucleolar RNA; H/ACA box snoRNA, H/ACA box small nucleolar RNA; scaRNA, small cajal body-specific RNA.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-58597-fig1-v2.tif"/></fig><fig id="fig1s1" position="float" specific-use="child-fig"><label>Figure 1—figure supplement 1.</label><caption><title>Ingenuity pathway analysis of significant protein-coding RNA in sepsis relative to health.</title><p>Red bars denote pathways harboring protein-coding RNA with elevated expression; turquoise bars denote pathways harboring protein-coding RNA with reduced expression. Significance was demarcated at Benjamini–Hochberg (BH) adjusted p&lt;0.01. −log(BH) p, negative log-transformed BH p-value.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-58597-fig1-figsupp1-v2.tif"/></fig></fig-group><p>Comparing sepsis patients to healthy subjects identified 15,097, 13,158, and 635 significantly altered (adjusted p-value &lt;0.01) protein-coding, long non-coding, and small non-coding RNAs, respectively (<xref ref-type="fig" rid="fig1">Figure 1C</xref>). Ingenuity pathway analysis of the significantly altered protein-coding RNA transcripts revealed associations with various canonical signaling pathways that included elevated pro- and anti-inflammatory pathways, cell cycle, DNA damage response, and metabolic pathways (<xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1</xref>). Transcripts with reduced expression were predominantly associated with T helper cell activation, antigen presentation, and B cell responses. Results on protein-coding RNA profiles are in agreement with previous reports from our and other groups (<xref ref-type="bibr" rid="bib65">van der Poll et al., 2017</xref>). LincRNAs, antisense, and pseudogene RNA transcripts represented the most highly altered long non-coding RNA biotypes in sepsis relative to health (<xref ref-type="fig" rid="fig1">Figure 1D</xref>). Micro (mi)RNAs, stem loop RNAs, and small nucleolar (sno)RNAs were the most abundant small non-coding RNA biotypes (<xref ref-type="fig" rid="fig1">Figure 1E</xref>).</p></sec><sec id="s2-2"><title>Protein-coding and non-coding blood transcriptomes, demographics, and clinical characteristics</title><p>In order to understand inter-individual variation in RNA expression profiles, we set out to determine the contribution of demographics and clinical characteristics to protein-coding and non-coding RNA expression variation in sepsis patients (<xref ref-type="fig" rid="fig2">Figure 2</xref>), as well as healthy subjects. Using a variance partition (multivariable) approach (<xref ref-type="bibr" rid="bib29">Hoffman and Schadt, 2016</xref>), differences in gender and age of healthy subjects explained 5%, 4%, and 4% of the variation in protein-coding, long non-coding, and small non-coding RNA expression, respectively (<xref ref-type="fig" rid="fig2s1">Figure 2—figure supplement 1A</xref>). Specific transcripts had high percentages of explainable variance, in particular long non-coding RNAs against gender. Not surprisingly, expression of long non-coding RNAs positioned on the X and Y chromosomes, for example <italic>TXLNGY</italic>, <italic>LINC00278</italic>, and <italic>XIST</italic> had 98%, 97%, and 94% of variance explained by gender, respectively (<xref ref-type="fig" rid="fig2s1">Figure 2—figure supplement 1B</xref>). In sepsis patients, a multivariable model that incorporated demographics and common clinical characteristics, including APACHE IV, SOFA scores, shock and Charlson comorbidity indices, cumulatively explained 18%, 13%, and 8% of protein-coding, long non-coding, and small non-coding RNA expression variance, respectively (<xref ref-type="fig" rid="fig2">Figure 2A</xref>). Specifically, sepsis primary site of infection (lung or abdomen) and place of acquisition (community or hospital) explained the highest proportion of variation in protein-coding (6.7%) and long non-coding (4.4%) RNA expression (<xref ref-type="fig" rid="fig2">Figure 2A</xref>). Despite overall low proportions of variance explained, outlier RNA transcripts could be detected. For example, some specific transcripts demonstrated high individual explained variance against primary sepsis diagnosis, including protein-coding RNA encoding basic leucine zipper and W2 domains 1 (BZW1); long non-coding RNA SUMO2 pseudogene 1 (SUMO2P1); and small non-coding RNA miRNA hsa-miR-7855–5 p (<xref ref-type="fig" rid="fig2">Figure 2B</xref>). Septic shock explained low proportions of variation in RNA expression (<xref ref-type="fig" rid="fig2">Figure 2A</xref>), and directly comparing patients with septic shock to patients without shock resulted in 837 and 80 significantly altered protein-coding and long non-coding RNA, respectively (<xref ref-type="fig" rid="fig2">Figure 2C</xref>). High expression protein-coding RNA included matrix metalloproteinase 8 (<italic>MMP8</italic>), resistin (<italic>RETN</italic>), and lipocalin 2 (<italic>LCN2</italic>). Low expression protein-coding RNA included a Na+/Ca2+ exchanger (<italic>SLC8A1</italic>), membrane metalloendopeptidase (<italic>MME</italic>), and interleukin (IL-) six receptor (<italic>IL6R</italic>). Long non-coding RNA included lincRNA lung cancer-associated transcript 1 (<italic>LUCAT1</italic>; low expression) and antisense RNA (<italic>LRRC75A-AS1</italic>; high expression) (<xref ref-type="fig" rid="fig2">Figure 2C</xref>). No significant alterations were identified in small non-coding RNA expression profiles. Evaluating RNA expression in patients discordant for survival after 28 days identified 146 significantly altered protein-coding RNA (<xref ref-type="fig" rid="fig2s1">Figure 2—figure supplement 1C</xref>). No significant differences were uncovered in non-coding RNA expression profiles, suggesting that non-coding RNA profiles obtained on ICU admission may not be suitable as mortality predictors.</p><fig-group><fig id="fig2" position="float"><label>Figure 2.</label><caption><title>Variance in coding and non-coding RNA expression attributed to demographics and clinical characteristics of sepsis patients.</title><p>(<bold>A</bold>) Violin plots of percent variation in protein-coding, long non-coding, and small non-coding RNA expression explained by sepsis patient demographics and clinical variables. Black dots depict outlier RNA transcripts. (<bold>B</bold>) Percent variance of select protein-coding and long non-coding RNA partitioned into the segment attributable to each demographic and clinical variable ranked by percent variation (&gt;20%) for primary diagnosis (site of infection and place of acquisition). (<bold>C</bold>) Volcano plots depicting the changes in protein-coding and long non-coding RNA in patients discordant for septic shock on ICU admission. Horizontal (black) line denotes the adjusted p-value threshold for significance (adjusted p≤0.01). Abbreviations: BC+, blood culture positive microbiology; diagnosis, infection site (lung or abdomen) and source (community or hospital); Charlson, Charlson comorbidity index; Apache IV, Acute Physiology and Chronic Health Evaluation; ICU, Intensive care unit; SOFA, Sequential Organ Failure Assessment.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-58597-fig2-v2.tif"/></fig><fig id="fig2s1" position="float" specific-use="child-fig"><label>Figure 2—figure supplement 1.</label><caption><title>Variance partition of protein-coding and non-coding RNA expression in health and differential expression in sepsis non-survivors relative to survivors.</title><p>(<bold>A</bold>) Violin plots of percent variation in protein-coding, long non-coding, and small non-coding RNA expression explained by age in gender in healthy subjects (n = 82). Black dots depict outlier RNA. (<bold>B</bold>) Expression of long non-coding RNA <italic>TXLNGY</italic>, <italic>LINC00278</italic>, and <italic>XIST</italic> in healthy males and females. (<bold>C</bold>) Volcano plot of significantly altered protein-coding RNA in non-survivors relative to survivors after 28 days since ICU admission. Horizontal (black) line denotes −log10 transformed adjusted p-value thresholds.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-58597-fig2-figsupp1-v2.tif"/></fig></fig-group></sec><sec id="s2-3"><title>Protein-coding and non-coding RNA profiles of sepsis patients relative to human endotoxemia</title><p>Previous studies have compared the protein-coding RNA response in patients with sepsis or trauma (non-septic) to the response after lipopolysaccharide (LPS) administration to healthy volunteers in a controlled clinical setting (human endotoxemia) (<xref ref-type="bibr" rid="bib17">Cheng et al., 2016</xref>; <xref ref-type="bibr" rid="bib11">Calvano et al., 2005</xref>; <xref ref-type="bibr" rid="bib54">Scicluna et al., 2013</xref>; <xref ref-type="bibr" rid="bib48">Perlee et al., 2018</xref>; <xref ref-type="bibr" rid="bib58">Seok et al., 2013</xref>; <xref ref-type="bibr" rid="bib72">Xiao et al., 2011</xref>; <xref ref-type="bibr" rid="bib62">Takao and Miyakawa, 2015</xref>). Here we sought to extend on those observations by evaluating long and small non-coding RNA expression in sepsis relative to temporal leukocyte responses in human endotoxemia (<xref ref-type="fig" rid="fig3">Figure 3</xref>). As previously reported in this model (<xref ref-type="bibr" rid="bib17">Cheng et al., 2016</xref>; <xref ref-type="bibr" rid="bib11">Calvano et al., 2005</xref>; <xref ref-type="bibr" rid="bib54">Scicluna et al., 2013</xref>; <xref ref-type="bibr" rid="bib48">Perlee et al., 2018</xref>), robust alterations in protein-coding RNA expression were noted after 2, 4, and 6 hr of LPS administration (<xref ref-type="fig" rid="fig3s1">Figure 3—figure supplement 1</xref>). Fold expression in sepsis (relative to health) was directly correlated with fold expression after 2, 4, and 6 hr LPS (<xref ref-type="fig" rid="fig3">Figure 3A</xref>). Long non-coding RNA expression was robustly altered in endotoxemia, with 2361, 5053, 2925, and 43 significant differences after 2, 4, 6, and 24 hr endotoxemia, respectively (<xref ref-type="fig" rid="fig3s2">Figure 3—figure supplement 2A</xref>). Pseudogenes, lincRNA, and antisense RNA were the most abundant long non-coding RNA biotypes (<xref ref-type="fig" rid="fig3">Figure 3B</xref>). Small non-coding RNA were modestly altered in human endotoxemia (<xref ref-type="fig" rid="fig3s2">Figure 3—figure supplement 2B</xref>). The most abundant biotypes of small RNA were miRNA (<xref ref-type="fig" rid="fig3">Figure 3C</xref>). Comparing fold expression in sepsis (relative to health) to human endotoxemia revealed significant correlations after 2, 4, and 6 hr of endotoxemia (<xref ref-type="fig" rid="fig3">Figure 3D</xref>). The highest r<sup>2</sup> was found for sepsis and 4 hr post-LPS (r<sup>2</sup> = 0.51). Correlation analysis of small RNA fold expression during endotoxemia against fold expression in sepsis revealed indirect correlations (<xref ref-type="fig" rid="fig3">Figure 3E</xref>).</p><fig-group><fig id="fig3" position="float"><label>Figure 3.</label><caption><title>Comparison of the coding and non-coding transcriptome in sepsis to human endotoxemia.</title><p>(<bold>A</bold>) Dot plots depicting the correlation between protein-coding RNA fold expression indices in sepsis (compared to health) and fold expression after 2, 4, 6, and 24 hr lipopolysaccharide (LPS) infusion relative to pre-LPS. (<bold>B</bold>) Pie chart illustrating the biotypes of significantly altered long non-coding RNA (adjusted p&lt;0.01) across endotoxemia time points (2, 4, 6, and 24 hr after 2 ng/kg LPS). LincRNA, long intergenic non-coding RNA; rRNA, ribosomal RNA; TEC, to be experimentally confirmed; Mt tRNA, mitochondrial transfer RNA; Mt rRNA, mitochondrial ribosomal RNA. (<bold>C</bold>) Pie chart showing the biotypes of significantly altered small non-coding RNA (adjusted p&lt;0.05) in human endotoxemia. miRNA, microRNA; snoRNA, small nucleolar RNA; C/D box snoRNA, C/D box small nucleolar RNA; H/ACA box snoRNA, H/ACA box small nucleolar RNA; scaRNA, small cajal body-specific RNA. (<bold>D</bold>) Dot plots illustrating the correlation between long non-coding RNA fold expression indices in sepsis (compared to health) and fold expression of 2, 4, 6, and 24 hr after LPS relative to pre-LPS. rho, Spearman’s coefficient. (<bold>E</bold>) Dot plots depicting the correlation between small non-coding RNA fold expression indices in sepsis (compared to health) and 2, 4, 6, and 24 hr after LPS relative to pre-LPS. rho, Spearman’s coefficient.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-58597-fig3-v2.tif"/></fig><fig id="fig3s1" position="float" specific-use="child-fig"><label>Figure 3—figure supplement 1.</label><caption><title>Comparing fold expression in sepsis (relative to health) to human endotoxemia.</title><p>(<bold>A</bold>) Volcano plot representation of significantly altered protein-coding RNA after 2, 4, 6, and 24 hr lipopolysaccharide (LPS) infusion relative to pre-LPS. Horizontal (black) line denotes −log10 transformed adjusted p-value threshold of 0.01. (<bold>B–D</bold>) Ingenuity pathway analysis of significant protein-coding RNA after 2, 4, and 6 hr human endotoxemia. Red bars denote pathways harboring protein-coding RNA with elevated expression; turquoise bars denote pathways harboring protein-coding RNA with reduced expression. Significance was demarcated at Benjamini–Hochberg (BH) adjusted p&lt;0.01. Adjusted P, negative log-transformed BH p-value.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-58597-fig3-figsupp1-v2.tif"/></fig><fig id="fig3s2" position="float" specific-use="child-fig"><label>Figure 3—figure supplement 2.</label><caption><title>Volcano plot representations of significantly altered.</title><p>(<bold>A</bold>) Long non-coding RNA and (<bold>B</bold>) small non-coding RNA after 2, 4, 6, and 24 hr lipopolysaccharide (LPS) relative to pre-LPS. Horizontal (black) line denotes −log10 transformed adjusted p-value thresholds.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-58597-fig3-figsupp2-v2.tif"/></fig></fig-group></sec><sec id="s2-4"><title>Functional inference of non-coding RNA</title><p>To better understand the functional organization of the non-coding leukocyte transcriptome in sepsis, particularly long non-coding RNA, we undertook a guilt-by-association approach. On the basis of a bi-weight midcorrelation matrix of the most variable protein-coding and long non-coding RNA (n = 8539; coefficient of variation &gt;5%) in sepsis patients only (<xref ref-type="fig" rid="fig4">Figure 4</xref>), a weighted network was built with scale-free topology (<xref ref-type="fig" rid="fig4s1">Figure 4—figure supplement 1A</xref>; <xref ref-type="bibr" rid="bib36">Langfelder and Horvath, 2008</xref>; <xref ref-type="bibr" rid="bib37">Langfelder and Horvath, 2012</xref>; <xref ref-type="bibr" rid="bib55">Scicluna et al., 2015a</xref>). Hierarchical clustering uncovered 23 network modules (clusters) each harboring more than 100 inter-correlating RNA transcripts (<xref ref-type="fig" rid="fig4">Figure 4A</xref> and <xref ref-type="fig" rid="fig4s1">Figure 4—figure supplement 1B</xref>). Of the 8539 RNA transcripts, 158 transcripts did not cluster (designated as a gray module). Seventeen modules were associated with specific gene ontologies or canonical signaling pathways that included cell death/olfactory receptor activity/cell-cycle G2/M DNA damage checkpoint and regulation (turquoise module, n = 1001 transcripts) and RNA biosynthesis/RNA binding (yellow module, n = 579 transcripts) (<xref ref-type="fig" rid="fig4">Figure 4A</xref>). Eight modules in the co-expression network were significantly enriched for long non-coding RNA relative to protein-coding RNA (Fisher’s adjusted p&lt;0.01; <xref ref-type="fig" rid="fig4">Figure 4B</xref>). This suggests that the leukocyte long non-coding transcriptome of sepsis patients is primarily co-expressed with protein-coding RNA, but 34% of non-coding RNA modules were organized into distinct units. Evaluation of total and intra-module connectivities, which measure the importance of each module relative to the overall structure of co-expression networks (<xref ref-type="bibr" rid="bib36">Langfelder and Horvath, 2008</xref>), identified two ‘driver’ modules, namely the cell death/olfactory receptor activity/cell-cycle G2/M DNA damage checkpoint and regulation (turquoise module, n = 1001 transcripts) and RNA biosynthesis/RNA binding (yellow module, n = 579 transcripts) modules (<xref ref-type="fig" rid="fig4">Figure 4C and D</xref> and <xref ref-type="fig" rid="fig4s1">Figure 4—figure supplement 1C</xref>). The former module included protein-coding RNA encoding ATM serine/threonine kinase (<italic>ATM</italic>), TNF alpha-induced protein 3 (<italic>TNFAIP3</italic> or A20), histone deacetylase 2 (<italic>HDAC2</italic>), and mucosa-associated lymphoid tissue lymphoma translocation protein 1 (<italic>MALT1</italic>) paracaspase (<xref ref-type="fig" rid="fig4">Figure 4D</xref>). Non-coding RNA included <italic>GABPB1-AS1</italic>, <italic>THAP9-AS1</italic>, and <italic>SCARNA9</italic>. We subsequently focused our attention on integrating miRNA profiles to the co-expression network. Considering miRNA profiles that were significantly altered in sepsis patients relative to health (<xref ref-type="fig" rid="fig1">Figure 1C</xref>), and miRNA-to-gene interactions (miRWalk method), we detected 49 small RNAs in five network modules with explained variance estimated &gt;20%, including <italic>hsa-miR-200c-3p</italic> (translation initiation module), <italic>SNORD84</italic> (regulation of cytokine secretion/Toll-like receptor [TLR] signaling module), <italic>HBII-276</italic> (translation initiation module), <italic>hsa-miR-1275</italic> (sensory perception of chemical stimulus/olfactory receptor activity module), and <italic>hsa-miR-664b-3p</italic> (neutrophil degranulation/extracellular exosome module) (<xref ref-type="fig" rid="fig4">Figure 4E</xref>). Of note, <italic>hsa-miR-200c-3p</italic> has been shown to modify TLR4 signaling efficiency dependent on MYD88-mediated pathways in an embryonic kidney cell line (HEK293) (<xref ref-type="bibr" rid="bib69">Wendlandt et al., 2012</xref>).</p><fig-group><fig id="fig4" position="float"><label>Figure 4.</label><caption><title>Network analysis of coding and non-coding RNA expression.</title><p>(<bold>A</bold>) Circular plot of protein-coding and long non-coding co-expression network modules characterized by significantly associated (Fisher’s adjusted p&lt;0.01) gene ontologies and Ingenuity canonical signaling pathways. Seventeen modules were associated with specific ontologies or canonical signaling pathways. (<bold>B</bold>) Bar plot depicting the distribution of protein coding and long non-coding RNA in each network module. *Fisher’s Benjamini–Hochberg adjusted p&lt;0.01. (<bold>C</bold>) Dot plot illustrating the correlation between intramodular and total connectivities of each RNA transcript in their respective network module. Yellow dots illustrate protein-coding and long non-coding RNA in the RNA biosynthesis/RNA binding module; Turquoise dots depict the cell death and olfactory receptor activity module. (<bold>D</bold>) Diagrammatic representation of Ingenuity’s biofunctions (z-score &lt;2 or &gt;2 and adjusted p&lt;0.05) together with predicted long intergenic non-coding RNA (lincRNA) and antisense RNA in the cell death/olfactory receptor activity/cell-cycle G2/M DNA damage checkpoint and regulation module (turquoise). Blue, reduced expression; red, elevated expression in sepsis relative to health (fold change ≥1.2 or ≤−1.2; adjusted p-value&lt;0.01). (<bold>E</bold>) Violin plots of network module eigengene (first principal component) percent variance attributable to small non-coding RNA.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-58597-fig4-v2.tif"/></fig><fig id="fig4s1" position="float" specific-use="child-fig"><label>Figure 4—figure supplement 1.</label><caption><title>Co-expression network analysis.</title><p>(<bold>A</bold>) Evaluation of scale free topology model fit and mean connectivities (y-axes) across various soft threshold powers (x-axis) with scale independence denoted at R<sup>2</sup> &gt; 0.85 (red horizontal line) for protein-coding and long non-coding RNA expression in sepsis patients (n = 8539). (<bold>B</bold>) Topological overlap plot of adjacencies calculated for 8539 protein-coding and long non-coding RNA expression and module colors. (<bold>C</bold>) Cytoscape plot (organic layout) of protein-coding and long non-coding RNA (nodes) and connectivities (edges; weight &gt;0.2). Turquoise and yellow modules were visibly central to the co-expression network.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-58597-fig4-figsupp1-v2.tif"/></fig></fig-group><p>Next, we evaluated the association of network modules with soluble mediators of the host response and clinical severity scores. Neutrophil degranulation (secretory; red), protein ubiquitination (pink), and mitotic cell cycle (tan) modules correlated with soluble mediators of inflammation (C reactive protein [CRP], IL-6, IL-10, IL-8), endothelial responses (E-selectin and angiopoietin-2 [ANG2]), coagulation (D-Dimer), and clinical variables of disease severity (<xref ref-type="fig" rid="fig5">Figure 5A</xref>). In contrast, antigen presentation/Th1-Th2 cell activation (green module), regulation of cytokine secretion/TLR signaling (black module), and type-I interferon signaling/double stranded RNA binding (salmon module) were indirectly correlated with various soluble mediators and clinical severity indices. Patients with septic shock showed significantly higher neutrophil degranulation (secretory) expression patterns (<xref ref-type="fig" rid="fig5">Figure 5B</xref>). Protein-coding RNA transcripts in the neutrophil degranulation (secretory) module included matrix metalloproteinases (<italic>MMP8</italic> and <italic>MMP9</italic>), neutrophil activation cluster of differentiation 177 (<italic>CD177</italic>), lipocalin 2 (<italic>LCN2</italic>), and arginase 1 (<italic>ARG1</italic>) (<xref ref-type="fig" rid="fig5">Figure 5C</xref>). LincRNA and antisense RNA included an inducer of differentiation <italic>MYOSLID</italic> (myocardin-induced smooth muscle LncRNA, inducer of differentiation), cell proliferation, and metastasis-associated antisense RNA of the titin gene (<italic>TTN-AS1</italic>) and an IL10 receptor beta subunit antisense RNA, <italic>IL10RB-AS1</italic>. Calculating intra-modular connectivities enabled us to define ‘hub’ transcripts, which are understood to represent cogs in the functional output of a network module (<xref ref-type="bibr" rid="bib36">Langfelder and Horvath, 2008</xref>; <xref ref-type="bibr" rid="bib73">Zhao et al., 2010</xref>), and identified <italic>MYOSLID</italic> (neutrophil degranulation; red module) and <italic>LUCAT1</italic> (Lung Cancer Associated Transcript 1) in the TLR-signaling (black) module, as module ‘hubs’. In line with their respective module eigengene correlations with inflammatory response markers, <italic>MYOSLID</italic> expression was directly correlated with levels of inflammatory response markers IL-6, IL-8, IL-10, and acute phase response protein CRP (<xref ref-type="fig" rid="fig5">Figure 5D</xref>). In contrast, <italic>LUCAT1</italic> expression was indirectly correlated with soluble mediators of inflammation, except for CRP (<xref ref-type="fig" rid="fig5">Figure 5E</xref>).</p><fig id="fig5" position="float"><label>Figure 5.</label><caption><title>Relationship of protein-coding, non-coding RNA network modules to soluble mediators and clinical severity.</title><p>(<bold>A</bold>) Heatmap representation of Pearson correlation coefficients (adjusted p&lt;0.05) calculated for each network module eigengene (first principal component) against soluble mediators of inflammation, endothelial function, coagulation, as well as clinical parameters of disease severity. APACHE IV, Acute Physiology and Chronic Health Evaluation; SOFA, Sequential Organ Failure Assessment. Red denotes direct correlations and blue denotes indirect correlations (<bold>B</bold>) Boxplot showing differences in neutrophil degranulation (red) module eigengene values in sepsis patients discordant for septic shock on intensive care unit admission. High module eigengene values mean overall elevated RNA expression; low module eigengene values mean reduced expression. (<bold>C</bold>) Diagrammatic representation of the neutrophil degranulation (secretory; red) module (Ingenuity’s biofunction z-score &lt;2 or &gt;2; adjusted p&lt;0.05) together with predicted long intergenic non-coding RNA (lincRNA) and antisense RNA. Red or blue nodes denote high or low expression RNA transcripts in sepsis relative to health, respectively. ***Mann–Whitney p&lt;0.001. (<bold>D and E</bold>) Dot plots of (<bold>D</bold>) <italic>MYOSLID</italic> expression and (<bold>E</bold>) <italic>LUCAT1</italic> expression against soluble mediators of inflammation IL-6, IL-8, and IL-10, as well as the acute phase response protein CRP. Rho, Spearman’s coefficient.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-58597-fig5-v2.tif"/></fig></sec></sec><sec id="s3" sec-type="discussion"><title>Discussion</title><p>In this study we found that the transcriptional changes in critically ill patients with sepsis are not exclusive to protein-coding RNAs. Whole blood long non-coding RNAs, and to a lesser extent small non-coding RNAs, were significantly altered in sepsis patients relative to healthy subjects. The pattern of protein-coding and long non-coding RNA profiles in sepsis was mimicked by expression profiles in a human endotoxemia model, notably at a time point indicative of endotoxin tolerance. Small non-coding RNA profiles in sepsis patients were not recapitulated in human endotoxemia. In general, common clinical characteristics explained low proportions of variation in protein-coding and non-coding RNA profiles, suggesting that variation in leukocyte responses are largely not explained by clinical parameters. Leveraging on the concepts of network biology, protein-coding and non-coding RNA were clustered as functional biological units with RNA binding/RNA biosynthesis and cell death/olfactory receptor activity/cell-cycle G2-M DNA damage checkpoint and regulation modules central to network architecture.</p><p>Advances in genomics, notably massively parallel cDNA sequencing, have shown that active transcription is not exclusive to protein-coding RNA regions (<xref ref-type="bibr" rid="bib12">Carninci et al., 2005</xref>). Regions of the genome void of protein-coding genes have since been shown to be actively transcribed in the context of various diseases (<xref ref-type="bibr" rid="bib24">Esteller, 2011</xref>). Small non-coding RNAs, mainly microRNAs, as well as long non-coding RNAs were linked to specific immune processes (<xref ref-type="bibr" rid="bib45">Mehta and Baltimore, 2016</xref>; <xref ref-type="bibr" rid="bib26">Fitzgerald and Caffrey, 2014</xref>). While microRNAs have been established as veritable epigenetic modifiers of transcriptional outputs, studies on the functional aspects of long non-coding RNAs have only recently begun. However, those studies were centered primarily on mouse models (<xref ref-type="bibr" rid="bib3">Atianand et al., 2016</xref>; <xref ref-type="bibr" rid="bib13">Carpenter et al., 2013</xref>). This presents a problem for translation to human physiology because non-coding RNA sequences are typically not conserved between species (<xref ref-type="bibr" rid="bib20">Diederichs, 2014</xref>). Furthermore, expression of non-coding RNAs was shown to exhibit substantially higher inter-individual variation in healthy subjects as compared to protein-coding RNAs alone (<xref ref-type="bibr" rid="bib35">Kornienko et al., 2016</xref>). In line with those observations our data showed that long non-coding RNA expression patterns were far more variable across individuals (healthy or sepsis) than protein-coding and small non-coding RNAs. The sources of increased inter-individual variation in long non-coding RNA expression relative to protein-coding and small non-coding RNAs are as yet unknown. Lower conservation coupled with faster evolution rates of long non-coding RNA regions, which seemingly harbor more single nucleotide polymorphisms (SNPs) than protein-coding genes (<xref ref-type="bibr" rid="bib47">Necsulea and Kaessmann, 2014</xref>), as well as the possibility of their relatively higher susceptibility to environmental and lifestyle factors (<xref ref-type="bibr" rid="bib21">Dumeaux et al., 2010</xref>), may be at the basis of the extensive variation in long non-coding RNA expression.</p><p>In line with previous studies (<xref ref-type="bibr" rid="bib58">Seok et al., 2013</xref>; <xref ref-type="bibr" rid="bib62">Takao and Miyakawa, 2015</xref>), we found that protein-coding RNA alterations during endotoxemia mimicked those that ensue in sepsis patients. The human endotoxemia model is a highly relevant in vivo model of acute systemic inflammation in the context of a controlled clinical setting (<xref ref-type="bibr" rid="bib40">Lowry, 2005</xref>). In general, the model is characterized by a robust systemic response, including leukocyte transcriptional responses, exhibiting shared and unique temporal changes that resolve within 24 hr of bolus administration (<xref ref-type="bibr" rid="bib11">Calvano et al., 2005</xref>; <xref ref-type="bibr" rid="bib48">Perlee et al., 2018</xref>). In extension to the previously reported data, based on a single time-point of human endotoxemia (<xref ref-type="bibr" rid="bib58">Seok et al., 2013</xref>; <xref ref-type="bibr" rid="bib62">Takao and Miyakawa, 2015</xref>), we found that the correlation between sepsis and human endotoxemia was also dependent, at least in part, on timing of the response to LPS. The highest correlation was found at 4 hr, a time point at which the capacity of cytokine production by leukocytes is typically reduced in the human endotoxemia model, indicative of endotoxin tolerance (<xref ref-type="bibr" rid="bib17">Cheng et al., 2016</xref>; <xref ref-type="bibr" rid="bib19">de Vos et al., 2009</xref>). Long non-coding RNA alterations in human endotoxemia also mimicked those in sepsis, with similar time dependencies as protein-coding RNA. In contrast, small non-coding RNA expression profiles in sepsis patients were not reliably recapitulated in human endotoxemia, primarily showing indirect correlations. This may be due to typically low expression patterns of miRNA, compared to protein-coding and long non-coding RNA, and reported high specificities of miRNA to developmental stage and cell-type (<xref ref-type="bibr" rid="bib8">Bernstein et al., 2003</xref>). The host response during infection is characterized by a balance between resistance (seeking to limit the pathogen load) and tolerance (aiming to retain cell and organ functions) (<xref ref-type="bibr" rid="bib53">Schneider and Ayres, 2008</xref>). In sepsis both mechanisms can become uncontrolled, wherein aberrant activation of resistance pathways results in tissue damage and inadequate tolerance can cause immune suppression with enhanced susceptibility to secondary infections (<xref ref-type="bibr" rid="bib7">Bauer and Wetzker, 2020</xref>). While our time-sequential data in healthy humans injected with LPS suggest that coding and long non-coding RNA profiles in blood leukocytes of sepsis patients particularly reflect a tolerant state, time course studies in patients are needed to increase the insight into the role of distinct RNA species in the interplay between resistance and tolerance.</p><p>A substantial proportion of variance in protein-coding and non-coding RNA expression in critically ill patients with sepsis remained unexplained. Other sources of variation, not assessed in this study, include patient genetics and time between the onset of sepsis and ICU admission (<xref ref-type="bibr" rid="bib52">Schadt et al., 2003</xref>; <xref ref-type="bibr" rid="bib43">Maslove and Wong, 2014</xref>). The former represents an important source of inter-individual variation where SNPs segregating in populations are in part tightly related to RNA expression variability (<xref ref-type="bibr" rid="bib52">Schadt et al., 2003</xref>). This was shown in a recent prospective study in sepsis due to community-acquired pneumonia (CAP), wherein SNPs influencing gene expression patterns were identified (<xref ref-type="bibr" rid="bib18">Davenport et al., 2016</xref>). The time of onset of sepsis is a current ‘black box’ in the field as it cannot be accurately determined, thereby resulting in considerable uncertainty since patients are presumably admitted to the ICU at various stages of the sepsis syndrome. Overall, we determined that clinical characteristics and outcome explained low proportions of variation in RNA expression; however, specific protein-coding and long non-coding RNA transcripts had high percent variation attributable to, particularly, primary diagnosis that included infections site (lung or abdomen) and place of acquisition (community or hospital), which may constitute important proxies to discern organ-specific infections that are typically caused by different causal pathogens (<xref ref-type="bibr" rid="bib66">van Vught et al., 2016a</xref>; <xref ref-type="bibr" rid="bib67">van Vught et al., 2016b</xref>; <xref ref-type="bibr" rid="bib51">Sartelli, 2010</xref>).</p><p>Ascribing long non-coding RNA function to cellular biological pathways is a major challenge. To address this challenge, we undertook a guilt-by-association strategy that sought to position long non-coding RNA in co-expression modules of tightly correlating protein-coding RNA, thereby infer on functional outputs of long non-coding RNA by virtue of the pathways that associate with protein-coding RNA in each module. By leveraging on the concepts of scale free networks (<xref ref-type="bibr" rid="bib6">Barabási, 2009</xref>), we built a map of protein-coding and non-coding RNA relationships that pointed to cell death/olfactory receptor activity/cell-cycle G2/M DNA damage checkpoint and regulation (turquoise module) and RNA biosynthesis/RNA binding (yellow module) as central to the organization of the co-expression network. Cell death or exhaustion, particularly in lymphocytes, have been proposed as causal features of immunosuppression and lethality in sepsis (<xref ref-type="bibr" rid="bib30">Hotchkiss et al., 2013</xref>). Our findings further strengthen this hypothesis and position previously unknown non-coding RNA, including an autophagy and chemical stress responder <italic>GABPB1-AS1</italic> (<xref ref-type="bibr" rid="bib63">Tani et al., 2014</xref>; <xref ref-type="bibr" rid="bib41">Luan et al., 2019</xref>), as putative regulators of cell death in the context of sepsis. Interestingly, protein-coding RNA in the cell death (turquoise) module also included olfactory receptors and cell-cycle DNA damage regulators. Modulation of DNA damage responses was demonstrated as a potential therapeutic path that might be exploited to confer protection to severe sepsis (<xref ref-type="bibr" rid="bib25">Figueiredo et al., 2013</xref>). Little is known about olfactory receptors in non-chemosensory cells, but a growing body of evidence suggests they are not exclusive to the nose (<xref ref-type="bibr" rid="bib31">Kang and Koo, 2012</xref>). They have been shown to be involved in cell–cell recognition, migration, proliferation, and apoptosis (<xref ref-type="bibr" rid="bib44">Maßberg and Hatt, 2018</xref>).</p><p>In conclusion, we here describe the non-coding RNA landscape in blood leukocytes of sepsis patients upon admission to the ICU. By considering non-coding RNA expression patterns in relation to protein-coding RNA we provide an important layer to the blood leukocyte ‘regulome’ in a clinical context, which may facilitate prioritization of non-coding RNA in future functional studies.</p></sec><sec id="s4" sec-type="materials|methods"><title>Materials and methods</title><table-wrap id="keyresource" position="anchor"><label>Key resources table</label><table frame="hsides" rules="groups"><thead><tr><th>Reagent type <break/>(species) or <break/>resource</th><th>Designation</th><th>Source or <break/>reference</th><th>Identifiers</th><th>Additional <break/>information</th></tr></thead><tbody><tr><td>Biological sample (<italic>Homo sapiens</italic>)</td><td>Total RNA</td><td>Leukocytes</td><td/><td/></tr><tr><td>Commercial assay or kit</td><td>PAXgene Blood miRNA kit</td><td>Qiagen</td><td>Cat no./ID: 763134</td><td/></tr><tr><td>Commercial assay or kit</td><td>Human Transcriptome Array 2.0</td><td>Affymetrix; Thermo Fisher</td><td/><td>microarray</td></tr><tr><td>Commercial assay or kit</td><td>miRNA 4.1 96-array plate</td><td>Affymetrix; Thermo Fisher</td><td/><td>microarray</td></tr><tr><td>Commercial assay or kit</td><td>FlexSet cytometric bead arrays</td><td>BD Biosciences</td><td/><td/></tr><tr><td>Commercial assay or kit</td><td>Immunoturbidimetric assay</td><td>Roche diagnostics</td><td/><td/></tr><tr><td>Commercial assay or kit</td><td>Luminex Flow Cytometry Analyzer</td><td>Luminex Corp.</td><td>RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/SCR_018025">SCR_018025</ext-link></td><td/></tr><tr><td>Commercial assay or kit</td><td>Sysmex CA-1500 System</td><td>Siemens Healthineers</td><td/><td/></tr><tr><td>Chemical compound, drug</td><td>Lipopolysaccharide- <italic>Escherichia coli</italic>, 100 ng/ml, Ultrapure</td><td>Invivogen</td><td>Cat#0111:B4</td><td/></tr><tr><td>Software, algorithm</td><td>R Project for Statistical Computing, (version 3.5.0)</td><td>R Development Core Team</td><td>RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/SCR_001905">SCR_001905</ext-link></td><td/></tr><tr><td>Software, algorithm</td><td>Oligo (version 1.44)</td><td>Bioconductor (<xref ref-type="bibr" rid="bib15">Carvalho and Irizarry, 2010</xref>)</td><td>RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/SCR_015729">SCR_015729</ext-link></td><td/></tr><tr><td>Software, algorithm</td><td>SVA (version 3.28)</td><td>Bioconductor (<xref ref-type="bibr" rid="bib38">Leek and Storey, 2007</xref>)</td><td>RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/SCR_012836">SCR_012836</ext-link></td><td/></tr><tr><td>Software, algorithm</td><td>genefilter (version 1.62)</td><td>Bioconductor (<xref ref-type="bibr" rid="bib10">Bourgon et al., 2010</xref>)</td><td/><td/></tr><tr><td>Software, algorithm</td><td>arrayQualityMetrics</td><td>Bioconductor (<xref ref-type="bibr" rid="bib33">Kauffmann et al., 2009</xref>)</td><td>RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/SCR_001335">SCR_001335</ext-link></td><td/></tr><tr><td>Software, algorithm</td><td>Affymetrix Transcriptome Analysis Console</td><td>Affymetrix</td><td>RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/SCR_018718">SCR_018718</ext-link></td><td/></tr><tr><td>Software, algorithm</td><td>limma (version 3.36)</td><td>Bioconductor (<xref ref-type="bibr" rid="bib61">Smyth, 2005</xref>)</td><td><break/>RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/SCR_010943">SCR_010943</ext-link></td><td/></tr><tr><td>Software, algorithm</td><td>Ingenuity pathway analysis software</td><td>Qiagen</td><td>RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/SCR_008653">SCR_008653</ext-link></td><td/></tr><tr><td>Software, algorithm</td><td>WGCNA (version 1.64)</td><td>Bioconductor (<xref ref-type="bibr" rid="bib36">Langfelder and Horvath, 2008</xref>)</td><td>RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/SCR_003302">SCR_003302</ext-link></td><td/></tr><tr><td>Software, algorithm</td><td>miR-Walk 2.0</td><td>University of Heidelberg, Germany (<xref ref-type="bibr" rid="bib23">Dweep et al., 2011</xref>)</td><td/><td/></tr><tr><td>Software, algorithm</td><td>variancePartition (version 1.10)</td><td>Bioconductor (<xref ref-type="bibr" rid="bib29">Hoffman and Schadt, 2016</xref>)</td><td/><td/></tr><tr><td>Software, algorithm</td><td>mixOmics</td><td>Bioconductor (<xref ref-type="bibr" rid="bib50">Rohart et al., 2017</xref>)</td><td>RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/SCR_016889">SCR_016889</ext-link></td><td/></tr><tr><td>Other</td><td>Deposited data super-series</td><td>Gene Expression Omnibus</td><td>GSE134364</td><td/></tr></tbody></table></table-wrap><sec id="s4-1"><title>Patient population and inclusion criteria</title><p>This study was part of the Molecular Diagnosis and Risk Stratification of sepsis (MARS) project, a prospective observational study in the mixed ICUs of two tertiary teaching hospitals in the Netherlands (Academic Medical Center, Amsterdam and University Medical Center Utrecht, Utrecht) (<ext-link ext-link-type="uri" xlink:href="https://clinicaltrials.gov/">ClinicalTrials.gov</ext-link> identifier NCT01905033) (<xref ref-type="bibr" rid="bib66">van Vught et al., 2016a</xref>; <xref ref-type="bibr" rid="bib34">Klein Klouwenberg et al., 2013</xref>; <xref ref-type="bibr" rid="bib56">Scicluna et al., 2015b</xref>). For the current study, we selected consecutive patients with sepsis from the MARS biorepository who were older than 18 years of age and had been admitted to the ICU between July 2012 and January 2014. Sepsis (n = 156) was defined as the presence of CAP, hospital-acquired pneumonia (HAP), or intra-abdominal infection diagnosed within 24 hr of ICU admission with a culture proven or probable likelihood using criteria as described (<xref ref-type="bibr" rid="bib75">Zimmerman et al., 2006</xref>), accompanied by at least one additional general, inflammatory, hemodynamic, organ dysfunction, or tissue perfusion variable described in the third international consensus definitions for sepsis and septic shock (<xref ref-type="bibr" rid="bib59">Singer et al., 2016</xref>). Patients with aspiration pneumonia, with multiple sites of infection, and patients admitted to the ICU more than 2 days after the initiation of antibiotics were excluded. All readmissions and patients transferred from another ICU were also excluded, except when patients were referred to one of the study centers on the same day of presentation to the first ICU. Severity was assessed by APACHE IV (<xref ref-type="bibr" rid="bib75">Zimmerman et al., 2006</xref>) and SOFA score excluding the central nervous system component (<xref ref-type="bibr" rid="bib68">Vincent et al., 1996</xref>). Shock was qualified by the use of vasopressors (norepinephrine, epinephrine, or dopamine) for hypotension in a norepinephrine-equivalent dose of more than 0.1 µg/kg/min in patients with a SOFA score of at least 2 (<xref ref-type="bibr" rid="bib59">Singer et al., 2016</xref>). Blood was collected in PAXgene tubes (Becton-Dickinson, Breda, The Netherlands) and ethylenediaminetetraacetic acid (EDTA) vacutainer tubes within 24 hr of ICU admission. Definitions of comorbid and immunocompromised conditions are reported in the online data supplement.</p></sec><sec id="s4-2"><title>Healthy participants and endotoxemia</title><p>PAXgene and EDTA tubes were also obtained from 82 healthy subjects. Eight male subjects were exposed to intravenous LPS in a Phase I, randomized, single-blind, parallel group, placebo controlled study (<ext-link ext-link-type="uri" xlink:href="https://clinicaltrials.gov/">Clinicaltrials.gov</ext-link> identifier NCT02328612); the subjects who received placebo were used in the current study (<xref ref-type="bibr" rid="bib48">Perlee et al., 2018</xref>). Subjects were infused with LPS over 1 min (2 ng/kg; from Escherichia [<italic>E. coli</italic>], US standard reference endotoxin, kindly provided by Anthony Suffredini, National Institute of Health, Bethesda, MD). Whole blood was collected in PaxGene Blood tubes (Qiagen) before and 2, 4, 6, and 24 hr after LPS administration.</p></sec><sec id="s4-3"><title>Immunological markers</title><p>EDTA-anticoagulated blood plasma collected on ICU admission was used for soluble mediator measurements. IL-6, IL-8, IL-10, soluble intercellular adhesion molecule-1 (ICAM-1), soluble E-selectin, and fractalkine were measured using FlexSet cytometric bead arrays (BD Biosciences, San Jose, CA) using a FACS Calibur (Becton Dickinson, Franklin Lakes, NJ, NJ, USA). Neutrophil gelatinase-associated lipocalin (NGAL), ANG-1, ANG-2, protein C, antithrombin, matrix metalloproteinase (MMP)−8 (R and D Systems, Abingdon, UK), and D-dimer (Procartaplex, eBioscience, San Diego, CA) were measured by Luminex multiplex assay using a BioPlex 200 (BioRas, Hercules, CA). CRP was determined by an immunoturbidimetric assay (Roche diagnostics). Platelet counts were determined by hemocytometry, prothrombin time (PT), and activated partial thromboplastin time (aPTT) by using a photometric method with Dade Innovin Reagent or by Dade Actin FS Activated PTT Reagent, respectively (Siemens Healthcare Diagnostics). Normal biomarker values were obtained from 27 age- and sex-matched healthy subjects, except for CRP, platelet counts, PT, and aPTT (routine laboratory reference values).</p></sec><sec id="s4-4"><title>Microarrays and data processing</title><p>Total RNA was isolated by means of PaxGene blood miRNA isolation kit (Thermo-Fisher) as per manufacturer’s instructions. Quality RNA (Agilent 2100 Bioanalyzer, Agilent Technologies; RIN &gt; 6) was processed and hybridized to either the GeneChip Human Transcriptome Array (HTA) 2.0 (Thermo-Fisher) or the miRNA 4.1 96-array plate (Thermo-Fisher) following manufacturer’s instructions. Both arrays were done on all samples (sepsis patients, controls, and healthy subjects injected with LPS). Microarrays were scanned at the Cologne Center for Genomics, Cologne, Germany.</p><p>The HTA 2.0 scans (.CEL) were processed in the R language and environment for statistical computing version 3.5.0 (R Development Core Team, Foundation for Statistical Computing, Vienna, Austria). Following robust multi-average (RMA) background-correction, quantile normalization, and log<sub>2</sub>-transformation using the oligo method (version 1.44) (<xref ref-type="bibr" rid="bib15">Carvalho and Irizarry, 2010</xref>) data were evaluated for non-experimental chip effects by means of surrogate variable analysis (SVA; version 3.28) and adjusted using the combat method (<xref ref-type="bibr" rid="bib38">Leek and Storey, 2007</xref>). Probes were annotated using biomart (version 2.36.1) (<xref ref-type="bibr" rid="bib60">Smedley et al., 2015</xref>), and low expression probes were filtered by means of the genefilter method (version 1.62) (<xref ref-type="bibr" rid="bib10">Bourgon et al., 2010</xref>). The miRNA-4.1 scans (.CEL) were analyzed by means of Affymetrix Expression Console software (Thermo-Fisher). Probes were normalized using the RMA method and detection above background (DABG) probe level detection. <italic>Homo sapiens</italic> annotated probes with detection p-value &lt;0.05 in at least one sample were considered for downstream analyses. Quality of HTA2.0 and miRNA-4.1 arrays was evaluated by means of the arrayqualitymetrics R package (<xref ref-type="bibr" rid="bib33">Kauffmann et al., 2009</xref>). Comparisons between study groups were done using the limma method (version 3.36) (<xref ref-type="bibr" rid="bib61">Smyth, 2005</xref>) and significance was demarcated by Benjamini–Hochberg multiple test adjusted probabilities (adjusted p&lt;0.01). The linear model included age and sex as additive covariates. The MDTH index was calculated as described previously (<xref ref-type="bibr" rid="bib9">Berry et al., 2010</xref>; <xref ref-type="bibr" rid="bib22">Dunning et al., 2018</xref>). Ingenuity Pathway Analysis (Ingenuity systems, Qiagen) was used to determine the most significant canonical signaling pathways for elevated and reduced protein-coding RNA transcripts considering adjusted Fisher’s probabilities (adjusted p&lt;0.05) specifying the Ingenuity knowledgebase as reference and human species. All other parameters were default.</p><p>The novelty of our study, that is, profiling non-coding RNA expression in leukocytes of patients with sepsis, precludes an adequate study power estimation. However, considering known co-regulation with protein-coding RNA expression, we provide study power estimates based on previous observations in typical gene expression studies (<xref ref-type="bibr" rid="bib17">Cheng et al., 2016</xref>; <xref ref-type="bibr" rid="bib57">Scicluna et al., 2017</xref>; <xref ref-type="bibr" rid="bib18">Davenport et al., 2016</xref>). Considering a false discovery rate of 5%, beta error level 5% (95% power), and typical effect sizes greater than 0.25 in sepsis relative to health, a sample size of 42 per group was estimated. In addition, eight healthy volunteers in a human endotoxemia challenge would have more than 95% power to detect differences relative to pre-challenge (baseline) samples (<xref ref-type="bibr" rid="bib17">Cheng et al., 2016</xref>; <xref ref-type="bibr" rid="bib18">Davenport et al., 2016</xref>; <xref ref-type="bibr" rid="bib11">Calvano et al., 2005</xref>; <xref ref-type="bibr" rid="bib54">Scicluna et al., 2013</xref>; <xref ref-type="bibr" rid="bib48">Perlee et al., 2018</xref>; <xref ref-type="bibr" rid="bib58">Seok et al., 2013</xref>; <xref ref-type="bibr" rid="bib72">Xiao et al., 2011</xref>; <xref ref-type="bibr" rid="bib62">Takao and Miyakawa, 2015</xref>). Using a continuous model, we estimated that 156 patients would have more than 98% power to detect significant associations with demographic or clinical variables (false-discovery rates of 5%).</p></sec><sec id="s4-5"><title>Co-expression network and pathway analysis</title><p>The weighted gene co-expression network analysis (WGCNA) method (version 1.64) was used to build the leukocyte co-expression network as described previously (<xref ref-type="bibr" rid="bib36">Langfelder and Horvath, 2008</xref>; <xref ref-type="bibr" rid="bib55">Scicluna et al., 2015a</xref>; <xref ref-type="bibr" rid="bib73">Zhao et al., 2010</xref>). A pair-wise biweight midcorrelation matrix of the most variable transcripts (coefficient of variation &gt;5%) was transformed into an adjacency matrix by using a ‘soft’ power function of 8 ensuring scale-free topology (<xref ref-type="bibr" rid="bib36">Langfelder and Horvath, 2008</xref>; <xref ref-type="bibr" rid="bib73">Zhao et al., 2010</xref>). The adjacency matrix was further transformed into a topological overlap matrix to enable the identification of modules (clusters) encompassing highly inter-correlating RNA transcripts by using a dynamic tree cut method (version 1.63) (<xref ref-type="bibr" rid="bib36">Langfelder and Horvath, 2008</xref>; <xref ref-type="bibr" rid="bib73">Zhao et al., 2010</xref>). Modules were summarized by means of the eigengene value, defined as the first PC of the module expression matrix and the module membership measure. Protein-coding RNA in each module were analyzed for enrichment of gene ontologies for biological processes (GO:BP), molecular function (GO:MF), and cellular compartment (GO:CC) using the Gene Ontology Consortium database with significance defined by adjusted p-value &lt;0.05 (<ext-link ext-link-type="uri" xlink:href="http://www.geneontology.org">http://www.geneontology.org</ext-link>) (<xref ref-type="bibr" rid="bib2">Ashburner et al., 2000</xref>). Biofunctions were predicted using Ingenuity Pathways software (Ingenuity pathway analysis, Qiagen Bioinformatics) specifying activation z-score &lt;2 or &gt;2 and adjusted p-value &lt;0.05. The miR-Walk atlas of gene-miRNA-target interactions was used to evaluate predicted interactions of miRNA with module-specific genes by specifying the miR-Walk algorithm (<xref ref-type="bibr" rid="bib23">Dweep et al., 2011</xref>; <xref ref-type="bibr" rid="bib46">Mills et al., 2017</xref>). Human species annotations and 3’ untranslated region (UTR) interactions as well as a minimum seed length equating to seven were specified. All other parameters were default.</p></sec><sec id="s4-6"><title>Statistics</title><p>Statistical analysis was performed in the R statistical environment (v 3.5.0). Comparison of continuous data between categories was done with the Wilcoxon rank sum test. Correlation analysis of continuous data was performed using Pearson’s method unless otherwise stated as well as the coefficient of determination (r<sup>2</sup>). Categorical data were analyzed by Fisher exact tests or chi-squared tests. Multiple comparison (Benjamini–Hochberg) adjusted p-values &lt;0.05 defined significance. The proportion of variance in RNA expression explained by demographics and clinical characteristics was calculated using a multivariate approach implemented in the variancePartition method (version 1.10) (<xref ref-type="bibr" rid="bib29">Hoffman and Schadt, 2016</xref>). A multivariate linear model was fit including age, gender, primary diagnosis, total SOFA, APACHE IV scores, shock, and Charlson comorbidity indices. PC analysis was done using the mixOmics package, specifying 10 components (<xref ref-type="bibr" rid="bib50">Rohart et al., 2017</xref>). Data is presented in the form of volcano plots, pie charts, dot plots, bar charts, and circular and violin plots.</p></sec></sec></body><back><ack id="ack"><title>Acknowledgements</title><p>The authors thank all the patients and healthy volunteers who participated in this study, as well as the critical care nursing staff at both the AMC and UMCU ICUs. Members of the MARS consortium were: from Amsterdam University Medical Centers, location Academic Medical Center, University of Amsterdam, the Netherlands: Friso M de Beer, Lieuwe D J Bos, Gerie J Glas, Roosmarijn T M van Hooijdonk, Janneke Horn, Mischa A Huson, Laura R A Schouten, Marleen Straat, Luuk Wieske, Maryse A Wiewel, and Esther Witteveen; from University Medical Center Utrecht, Utrecht, the Netherlands: David SY Ong, Jos F Frencken, Maria E Koster-Brouwer, Kirsten van de Groep, and Diana M Verboom.</p></ack><sec id="s5" sec-type="additional-information"><title>Additional information</title><fn-group content-type="competing-interest"><title>Competing interests</title><fn fn-type="COI-statement" id="conf1"><p>No competing interests declared</p></fn></fn-group><fn-group content-type="author-contribution"><title>Author contributions</title><fn fn-type="con" id="con1"><p>Conceptualization, Data curation, Formal analysis, Investigation, Methodology, Writing - original draft</p></fn><fn fn-type="con" id="con2"><p>Formal analysis, Writing - review and editing</p></fn><fn fn-type="con" id="con3"><p>Resources, Writing - review and editing</p></fn><fn fn-type="con" id="con4"><p>Resources, Writing - review and editing</p></fn><fn fn-type="con" id="con5"><p>Resources, Writing - review and editing</p></fn><fn fn-type="con" id="con6"><p>Resources</p></fn><fn fn-type="con" id="con7"><p>Resources</p></fn><fn fn-type="con" id="con8"><p>Resources</p></fn><fn fn-type="con" id="con9"><p>Resources</p></fn><fn fn-type="con" id="con10"><p>Resources, Writing - review and editing</p></fn><fn fn-type="con" id="con11"><p>Resources, Funding acquisition, Writing - review and editing</p></fn><fn fn-type="con" id="con12"><p>Resources, Writing - review and editing</p></fn><fn fn-type="con" id="con13"><p>Conceptualization, Funding acquisition, Writing - original draft</p></fn><fn fn-type="con" id="con14"><p>Project administration</p></fn></fn-group><fn-group content-type="ethics-information"><title>Ethics</title><fn fn-type="other"><p>Human subjects: The institutional review boards of both participating centers approved an opt-out consent method (IRB No. 10-056C). The Dutch Central Committee on Research Involving Human Subjects and the Medical Ethics Committee of the Academic Medical Center, Amsterdam, the Netherlands, approved the study. Written informed consent was obtained from all healthy participants.</p></fn></fn-group></sec><sec id="s6" sec-type="supplementary-material"><title>Additional files</title><supplementary-material id="supp1"><label>Supplementary file 1.</label><caption><title>Table of causative pathogens in critically ill patients with sepsis (n = 156).</title><p>Percentages depict the proportion of infections caused by the pathogen indicated. In total, 192 pathogens were assigned to 156 infections. In 40 (25.6%) infections, more than one pathogen was assigned as causative.</p></caption><media mime-subtype="docx" mimetype="application" xlink:href="elife-58597-supp1-v2.docx"/></supplementary-material><supplementary-material id="transrepform"><label>Transparent reporting form</label><media mime-subtype="pdf" mimetype="application" xlink:href="elife-58597-transrepform-v2.pdf"/></supplementary-material></sec><sec id="s7" sec-type="data-availability"><title>Data availability</title><p>The datasets generated and analyzed in the current study are available in the Gene Expression Omnibus of the National Center for Biotechnology Information repository with primary data accession numbers GSE134364 (super-series), GSE134347 for patients and healthy volunteers (HTA 2.0 microarray), GSE134356 for the human endotoxemia model samples (HTA 2.0 microarray) and GSE134358 for all patients, healthy volunteers and human endotoxemia samples (miRNA-4.1 microarray).</p><p>The following datasets were generated:</p><p><element-citation id="dataset1" publication-type="data" specific-use="isSupplementedBy"><person-group person-group-type="author"><name><surname>Scicluna</surname><given-names>BP</given-names></name></person-group><year iso-8601-date="2020">2020</year><data-title>GEO super-series of patients and healthy volunteers</data-title><source>NCBI Gene Expression Omnibus</source><pub-id assigning-authority="NCBI" pub-id-type="accession" xlink:href="https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE134364">GSE134364</pub-id></element-citation></p><p><element-citation id="dataset2" publication-type="data" specific-use="isSupplementedBy"><person-group person-group-type="author"><name><surname>Scicluna</surname><given-names>BP</given-names></name></person-group><year iso-8601-date="2020">2020</year><data-title>HTA2.0 microarray data of patients and healthy volunteers</data-title><source>NCBI Gene Expression Omnibus</source><pub-id assigning-authority="NCBI" pub-id-type="accession" xlink:href="https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE134347">GSE134347</pub-id></element-citation></p><p><element-citation id="dataset3" publication-type="data" specific-use="isSupplementedBy"><person-group person-group-type="author"><name><surname>Scicluna</surname><given-names>BP</given-names></name></person-group><year iso-8601-date="2020">2020</year><data-title>HTA2.0 microarray data of human endotoxemia volunteers</data-title><source>NCBI Gene Expression Omnibus</source><pub-id assigning-authority="NCBI" pub-id-type="accession" xlink:href="https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE134356">GSE134356</pub-id></element-citation></p><p><element-citation id="dataset4" publication-type="data" specific-use="isSupplementedBy"><person-group person-group-type="author"><name><surname>Scicluna</surname><given-names>BP</given-names></name></person-group><year iso-8601-date="2020">2020</year><data-title>MicroRNA microarray data of patients, healthy volunteers and human endotoxemia volunteers</data-title><source>NCBI Gene Expression Omnibus</source><pub-id assigning-authority="NCBI" pub-id-type="accession" xlink:href="https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE134358">GSE134358</pub-id></element-citation></p></sec><ref-list><title>References</title><ref id="bib1"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Angus</surname> <given-names>DC</given-names></name><name><surname>van der Poll</surname> <given-names>T</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Severe Sepsis and septic shock</article-title><source>New England Journal of Medicine</source><volume>369</volume><fpage>840</fpage><lpage>851</lpage><pub-id pub-id-type="doi">10.1056/NEJMra1208623</pub-id></element-citation></ref><ref id="bib2"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ashburner</surname> <given-names>M</given-names></name><name><surname>Ball</surname> <given-names>CA</given-names></name><name><surname>Blake</surname> <given-names>JA</given-names></name><name><surname>Botstein</surname> <given-names>D</given-names></name><name><surname>Butler</surname> <given-names>H</given-names></name><name><surname>Cherry</surname> <given-names>JM</given-names></name><name><surname>Davis</surname> <given-names>AP</given-names></name><name><surname>Dolinski</surname> <given-names>K</given-names></name><name><surname>Dwight</surname> <given-names>SS</given-names></name><name><surname>Eppig</surname> <given-names>JT</given-names></name><name><surname>Harris</surname> <given-names>MA</given-names></name><name><surname>Hill</surname> <given-names>DP</given-names></name><name><surname>Issel-Tarver</surname> <given-names>L</given-names></name><name><surname>Kasarskis</surname> <given-names>A</given-names></name><name><surname>Lewis</surname> <given-names>S</given-names></name><name><surname>Matese</surname> <given-names>JC</given-names></name><name><surname>Richardson</surname> <given-names>JE</given-names></name><name><surname>Ringwald</surname> <given-names>M</given-names></name><name><surname>Rubin</surname> <given-names>GM</given-names></name><name><surname>Sherlock</surname> <given-names>G</given-names></name></person-group><year iso-8601-date="2000">2000</year><article-title>Gene ontology: tool for the unification of biology the gene ontology consortium</article-title><source>Nature Genetics</source><volume>25</volume><fpage>25</fpage><lpage>29</lpage><pub-id pub-id-type="doi">10.1038/75556</pub-id><pub-id pub-id-type="pmid">10802651</pub-id></element-citation></ref><ref id="bib3"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Atianand</surname> <given-names>MK</given-names></name><name><surname>Hu</surname> <given-names>W</given-names></name><name><surname>Satpathy</surname> <given-names>AT</given-names></name><name><surname>Shen</surname> <given-names>Y</given-names></name><name><surname>Ricci</surname> <given-names>EP</given-names></name><name><surname>Alvarez-Dominguez</surname> <given-names>JR</given-names></name><name><surname>Bhatta</surname> <given-names>A</given-names></name><name><surname>Schattgen</surname> <given-names>SA</given-names></name><name><surname>McGowan</surname> <given-names>JD</given-names></name><name><surname>Blin</surname> <given-names>J</given-names></name><name><surname>Braun</surname> <given-names>JE</given-names></name><name><surname>Gandhi</surname> <given-names>P</given-names></name><name><surname>Moore</surname> <given-names>MJ</given-names></name><name><surname>Chang</surname> <given-names>HY</given-names></name><name><surname>Lodish</surname> <given-names>HF</given-names></name><name><surname>Caffrey</surname> <given-names>DR</given-names></name><name><surname>Fitzgerald</surname> <given-names>KA</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>A long noncoding RNA lincRNA-EPS acts as a transcriptional Brake to restrain inflammation</article-title><source>Cell</source><volume>165</volume><fpage>1672</fpage><lpage>1685</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2016.05.075</pub-id><pub-id pub-id-type="pmid">27315481</pub-id></element-citation></ref><ref id="bib4"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Atianand</surname> <given-names>MK</given-names></name><name><surname>Fitzgerald</surname> <given-names>KA</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Long non-coding RNAs and control of gene expression in the immune system</article-title><source>Trends in Molecular Medicine</source><volume>20</volume><fpage>623</fpage><lpage>631</lpage><pub-id pub-id-type="doi">10.1016/j.molmed.2014.09.002</pub-id><pub-id pub-id-type="pmid">25262537</pub-id></element-citation></ref><ref id="bib5"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bao</surname> <given-names>Z</given-names></name><name><surname>Yang</surname> <given-names>Z</given-names></name><name><surname>Huang</surname> <given-names>Z</given-names></name><name><surname>Zhou</surname> <given-names>Y</given-names></name><name><surname>Cui</surname> <given-names>Q</given-names></name><name><surname>Dong</surname> <given-names>D</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>LncRNADisease 2.0: an updated database of long non-coding RNA-associated diseases</article-title><source>Nucleic Acids Research</source><volume>47</volume><fpage>D1034</fpage><lpage>D1037</lpage><pub-id pub-id-type="doi">10.1093/nar/gky905</pub-id><pub-id pub-id-type="pmid">30285109</pub-id></element-citation></ref><ref id="bib6"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Barabási</surname> <given-names>AL</given-names></name></person-group><year iso-8601-date="2009">2009</year><article-title>Scale-free networks: a decade and beyond</article-title><source>Science</source><volume>325</volume><fpage>412</fpage><lpage>413</lpage><pub-id pub-id-type="doi">10.1126/science.1173299</pub-id><pub-id pub-id-type="pmid">19628854</pub-id></element-citation></ref><ref id="bib7"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bauer</surname> <given-names>M</given-names></name><name><surname>Wetzker</surname> <given-names>R</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>The cellular basis of organ failure in sepsis-signaling during damage and repair processes</article-title><source>Medizinische Klinik - Intensivmedizin Und Notfallmedizin</source><volume>115</volume><fpage>4</fpage><lpage>9</lpage><pub-id pub-id-type="doi">10.1007/s00063-020-00673-4</pub-id><pub-id pub-id-type="pmid">32236799</pub-id></element-citation></ref><ref id="bib8"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bernstein</surname> <given-names>E</given-names></name><name><surname>Kim</surname> <given-names>SY</given-names></name><name><surname>Carmell</surname> <given-names>MA</given-names></name><name><surname>Murchison</surname> <given-names>EP</given-names></name><name><surname>Alcorn</surname> <given-names>H</given-names></name><name><surname>Li</surname> <given-names>MZ</given-names></name><name><surname>Mills</surname> <given-names>AA</given-names></name><name><surname>Elledge</surname> <given-names>SJ</given-names></name><name><surname>Anderson</surname> <given-names>KV</given-names></name><name><surname>Hannon</surname> <given-names>GJ</given-names></name></person-group><year iso-8601-date="2003">2003</year><article-title>Dicer is essential for mouse development</article-title><source>Nature Genetics</source><volume>35</volume><fpage>215</fpage><lpage>217</lpage><pub-id pub-id-type="doi">10.1038/ng1253</pub-id><pub-id pub-id-type="pmid">14528307</pub-id></element-citation></ref><ref id="bib9"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Berry</surname> <given-names>MP</given-names></name><name><surname>Graham</surname> <given-names>CM</given-names></name><name><surname>McNab</surname> <given-names>FW</given-names></name><name><surname>Xu</surname> <given-names>Z</given-names></name><name><surname>Bloch</surname> <given-names>SA</given-names></name><name><surname>Oni</surname> <given-names>T</given-names></name><name><surname>Wilkinson</surname> <given-names>KA</given-names></name><name><surname>Banchereau</surname> <given-names>R</given-names></name><name><surname>Skinner</surname> <given-names>J</given-names></name><name><surname>Wilkinson</surname> <given-names>RJ</given-names></name><name><surname>Quinn</surname> <given-names>C</given-names></name><name><surname>Blankenship</surname> <given-names>D</given-names></name><name><surname>Dhawan</surname> <given-names>R</given-names></name><name><surname>Cush</surname> <given-names>JJ</given-names></name><name><surname>Mejias</surname> <given-names>A</given-names></name><name><surname>Ramilo</surname> <given-names>O</given-names></name><name><surname>Kon</surname> <given-names>OM</given-names></name><name><surname>Pascual</surname> <given-names>V</given-names></name><name><surname>Banchereau</surname> <given-names>J</given-names></name><name><surname>Chaussabel</surname> <given-names>D</given-names></name><name><surname>O'Garra</surname> <given-names>A</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>An interferon-inducible neutrophil-driven blood transcriptional signature in human tuberculosis</article-title><source>Nature</source><volume>466</volume><fpage>973</fpage><lpage>977</lpage><pub-id pub-id-type="doi">10.1038/nature09247</pub-id><pub-id pub-id-type="pmid">20725040</pub-id></element-citation></ref><ref id="bib10"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bourgon</surname> <given-names>R</given-names></name><name><surname>Gentleman</surname> <given-names>R</given-names></name><name><surname>Huber</surname> <given-names>W</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>Independent filtering increases detection power for high-throughput experiments</article-title><source>PNAS</source><volume>107</volume><fpage>9546</fpage><lpage>9551</lpage><pub-id pub-id-type="doi">10.1073/pnas.0914005107</pub-id><pub-id pub-id-type="pmid">20460310</pub-id></element-citation></ref><ref id="bib11"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Calvano</surname> <given-names>SE</given-names></name><name><surname>Xiao</surname> <given-names>W</given-names></name><name><surname>Richards</surname> <given-names>DR</given-names></name><name><surname>Felciano</surname> <given-names>RM</given-names></name><name><surname>Baker</surname> <given-names>HV</given-names></name><name><surname>Cho</surname> <given-names>RJ</given-names></name><name><surname>Chen</surname> <given-names>RO</given-names></name><name><surname>Brownstein</surname> <given-names>BH</given-names></name><name><surname>Cobb</surname> <given-names>JP</given-names></name><name><surname>Tschoeke</surname> <given-names>SK</given-names></name><name><surname>Miller-Graziano</surname> <given-names>C</given-names></name><name><surname>Moldawer</surname> <given-names>LL</given-names></name><name><surname>Mindrinos</surname> <given-names>MN</given-names></name><name><surname>Davis</surname> <given-names>RW</given-names></name><name><surname>Tompkins</surname> <given-names>RG</given-names></name><name><surname>Lowry</surname> <given-names>SF</given-names></name><collab>Inflamm and Host Response to Injury Large Scale Collab. Res. Program</collab></person-group><year iso-8601-date="2005">2005</year><article-title>A network-based analysis of systemic inflammation in humans</article-title><source>Nature</source><volume>437</volume><fpage>1032</fpage><lpage>1037</lpage><pub-id pub-id-type="doi">10.1038/nature03985</pub-id><pub-id pub-id-type="pmid">16136080</pub-id></element-citation></ref><ref id="bib12"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Carninci</surname> <given-names>P</given-names></name><name><surname>Kasukawa</surname> <given-names>T</given-names></name><name><surname>Katayama</surname> <given-names>S</given-names></name><name><surname>Gough</surname> <given-names>J</given-names></name><name><surname>Frith</surname> <given-names>MC</given-names></name><name><surname>Maeda</surname> <given-names>N</given-names></name><name><surname>Oyama</surname> <given-names>R</given-names></name><name><surname>Ravasi</surname> <given-names>T</given-names></name><name><surname>Lenhard</surname> <given-names>B</given-names></name><name><surname>Wells</surname> <given-names>C</given-names></name><name><surname>Kodzius</surname> <given-names>R</given-names></name><name><surname>Shimokawa</surname> <given-names>K</given-names></name><name><surname>Bajic</surname> <given-names>VB</given-names></name><name><surname>Brenner</surname> <given-names>SE</given-names></name><name><surname>Batalov</surname> <given-names>S</given-names></name><name><surname>Forrest</surname> <given-names>AR</given-names></name><name><surname>Zavolan</surname> <given-names>M</given-names></name><name><surname>Davis</surname> <given-names>MJ</given-names></name><name><surname>Wilming</surname> <given-names>LG</given-names></name><name><surname>Aidinis</surname> <given-names>V</given-names></name><name><surname>Allen</surname> <given-names>JE</given-names></name><name><surname>Ambesi-Impiombato</surname> <given-names>A</given-names></name><name><surname>Apweiler</surname> <given-names>R</given-names></name><name><surname>Aturaliya</surname> <given-names>RN</given-names></name><name><surname>Bailey</surname> <given-names>TL</given-names></name><name><surname>Bansal</surname> <given-names>M</given-names></name><name><surname>Baxter</surname> <given-names>L</given-names></name><name><surname>Beisel</surname> <given-names>KW</given-names></name><name><surname>Bersano</surname> <given-names>T</given-names></name><name><surname>Bono</surname> <given-names>H</given-names></name><name><surname>Chalk</surname> <given-names>AM</given-names></name><name><surname>Chiu</surname> <given-names>KP</given-names></name><name><surname>Choudhary</surname> <given-names>V</given-names></name><name><surname>Christoffels</surname> <given-names>A</given-names></name><name><surname>Clutterbuck</surname> <given-names>DR</given-names></name><name><surname>Crowe</surname> <given-names>ML</given-names></name><name><surname>Dalla</surname> <given-names>E</given-names></name><name><surname>Dalrymple</surname> <given-names>BP</given-names></name><name><surname>de Bono</surname> <given-names>B</given-names></name><name><surname>Della Gatta</surname> <given-names>G</given-names></name><name><surname>di Bernardo</surname> <given-names>D</given-names></name><name><surname>Down</surname> <given-names>T</given-names></name><name><surname>Engstrom</surname> <given-names>P</given-names></name><name><surname>Fagiolini</surname> <given-names>M</given-names></name><name><surname>Faulkner</surname> <given-names>G</given-names></name><name><surname>Fletcher</surname> <given-names>CF</given-names></name><name><surname>Fukushima</surname> <given-names>T</given-names></name><name><surname>Furuno</surname> <given-names>M</given-names></name><name><surname>Futaki</surname> <given-names>S</given-names></name><name><surname>Gariboldi</surname> <given-names>M</given-names></name><name><surname>Georgii-Hemming</surname> <given-names>P</given-names></name><name><surname>Gingeras</surname> <given-names>TR</given-names></name><name><surname>Gojobori</surname> <given-names>T</given-names></name><name><surname>Green</surname> <given-names>RE</given-names></name><name><surname>Gustincich</surname> <given-names>S</given-names></name><name><surname>Harbers</surname> <given-names>M</given-names></name><name><surname>Hayashi</surname> <given-names>Y</given-names></name><name><surname>Hensch</surname> <given-names>TK</given-names></name><name><surname>Hirokawa</surname> <given-names>N</given-names></name><name><surname>Hill</surname> <given-names>D</given-names></name><name><surname>Huminiecki</surname> <given-names>L</given-names></name><name><surname>Iacono</surname> <given-names>M</given-names></name><name><surname>Ikeo</surname> <given-names>K</given-names></name><name><surname>Iwama</surname> <given-names>A</given-names></name><name><surname>Ishikawa</surname> <given-names>T</given-names></name><name><surname>Jakt</surname> <given-names>M</given-names></name><name><surname>Kanapin</surname> <given-names>A</given-names></name><name><surname>Katoh</surname> <given-names>M</given-names></name><name><surname>Kawasawa</surname> <given-names>Y</given-names></name><name><surname>Kelso</surname> <given-names>J</given-names></name><name><surname>Kitamura</surname> <given-names>H</given-names></name><name><surname>Kitano</surname> <given-names>H</given-names></name><name><surname>Kollias</surname> <given-names>G</given-names></name><name><surname>Krishnan</surname> <given-names>SP</given-names></name><name><surname>Kruger</surname> <given-names>A</given-names></name><name><surname>Kummerfeld</surname> <given-names>SK</given-names></name><name><surname>Kurochkin</surname> <given-names>IV</given-names></name><name><surname>Lareau</surname> <given-names>LF</given-names></name><name><surname>Lazarevic</surname> <given-names>D</given-names></name><name><surname>Lipovich</surname> <given-names>L</given-names></name><name><surname>Liu</surname> <given-names>J</given-names></name><name><surname>Liuni</surname> <given-names>S</given-names></name><name><surname>McWilliam</surname> <given-names>S</given-names></name><name><surname>Madan Babu</surname> <given-names>M</given-names></name><name><surname>Madera</surname> <given-names>M</given-names></name><name><surname>Marchionni</surname> <given-names>L</given-names></name><name><surname>Matsuda</surname> <given-names>H</given-names></name><name><surname>Matsuzawa</surname> <given-names>S</given-names></name><name><surname>Miki</surname> <given-names>H</given-names></name><name><surname>Mignone</surname> <given-names>F</given-names></name><name><surname>Miyake</surname> <given-names>S</given-names></name><name><surname>Morris</surname> <given-names>K</given-names></name><name><surname>Mottagui-Tabar</surname> <given-names>S</given-names></name><name><surname>Mulder</surname> <given-names>N</given-names></name><name><surname>Nakano</surname> <given-names>N</given-names></name><name><surname>Nakauchi</surname> <given-names>H</given-names></name><name><surname>Ng</surname> <given-names>P</given-names></name><name><surname>Nilsson</surname> <given-names>R</given-names></name><name><surname>Nishiguchi</surname> <given-names>S</given-names></name><name><surname>Nishikawa</surname> <given-names>S</given-names></name><name><surname>Nori</surname> <given-names>F</given-names></name><name><surname>Ohara</surname> <given-names>O</given-names></name><name><surname>Okazaki</surname> <given-names>Y</given-names></name><name><surname>Orlando</surname> <given-names>V</given-names></name><name><surname>Pang</surname> <given-names>KC</given-names></name><name><surname>Pavan</surname> <given-names>WJ</given-names></name><name><surname>Pavesi</surname> <given-names>G</given-names></name><name><surname>Pesole</surname> <given-names>G</given-names></name><name><surname>Petrovsky</surname> <given-names>N</given-names></name><name><surname>Piazza</surname> <given-names>S</given-names></name><name><surname>Reed</surname> <given-names>J</given-names></name><name><surname>Reid</surname> <given-names>JF</given-names></name><name><surname>Ring</surname> <given-names>BZ</given-names></name><name><surname>Ringwald</surname> <given-names>M</given-names></name><name><surname>Rost</surname> <given-names>B</given-names></name><name><surname>Ruan</surname> <given-names>Y</given-names></name><name><surname>Salzberg</surname> <given-names>SL</given-names></name><name><surname>Sandelin</surname> <given-names>A</given-names></name><name><surname>Schneider</surname> <given-names>C</given-names></name><name><surname>Schönbach</surname> <given-names>C</given-names></name><name><surname>Sekiguchi</surname> <given-names>K</given-names></name><name><surname>Semple</surname> <given-names>CA</given-names></name><name><surname>Seno</surname> <given-names>S</given-names></name><name><surname>Sessa</surname> <given-names>L</given-names></name><name><surname>Sheng</surname> <given-names>Y</given-names></name><name><surname>Shibata</surname> <given-names>Y</given-names></name><name><surname>Shimada</surname> <given-names>H</given-names></name><name><surname>Shimada</surname> <given-names>K</given-names></name><name><surname>Silva</surname> <given-names>D</given-names></name><name><surname>Sinclair</surname> <given-names>B</given-names></name><name><surname>Sperling</surname> <given-names>S</given-names></name><name><surname>Stupka</surname> <given-names>E</given-names></name><name><surname>Sugiura</surname> <given-names>K</given-names></name><name><surname>Sultana</surname> <given-names>R</given-names></name><name><surname>Takenaka</surname> <given-names>Y</given-names></name><name><surname>Taki</surname> <given-names>K</given-names></name><name><surname>Tammoja</surname> <given-names>K</given-names></name><name><surname>Tan</surname> <given-names>SL</given-names></name><name><surname>Tang</surname> <given-names>S</given-names></name><name><surname>Taylor</surname> <given-names>MS</given-names></name><name><surname>Tegner</surname> <given-names>J</given-names></name><name><surname>Teichmann</surname> <given-names>SA</given-names></name><name><surname>Ueda</surname> <given-names>HR</given-names></name><name><surname>van Nimwegen</surname> <given-names>E</given-names></name><name><surname>Verardo</surname> <given-names>R</given-names></name><name><surname>Wei</surname> <given-names>CL</given-names></name><name><surname>Yagi</surname> <given-names>K</given-names></name><name><surname>Yamanishi</surname> <given-names>H</given-names></name><name><surname>Zabarovsky</surname> <given-names>E</given-names></name><name><surname>Zhu</surname> <given-names>S</given-names></name><name><surname>Zimmer</surname> <given-names>A</given-names></name><name><surname>Hide</surname> <given-names>W</given-names></name><name><surname>Bult</surname> <given-names>C</given-names></name><name><surname>Grimmond</surname> <given-names>SM</given-names></name><name><surname>Teasdale</surname> <given-names>RD</given-names></name><name><surname>Liu</surname> <given-names>ET</given-names></name><name><surname>Brusic</surname> <given-names>V</given-names></name><name><surname>Quackenbush</surname> <given-names>J</given-names></name><name><surname>Wahlestedt</surname> <given-names>C</given-names></name><name><surname>Mattick</surname> <given-names>JS</given-names></name><name><surname>Hume</surname> <given-names>DA</given-names></name><name><surname>Kai</surname> <given-names>C</given-names></name><name><surname>Sasaki</surname> <given-names>D</given-names></name><name><surname>Tomaru</surname> <given-names>Y</given-names></name><name><surname>Fukuda</surname> <given-names>S</given-names></name><name><surname>Kanamori-Katayama</surname> <given-names>M</given-names></name><name><surname>Suzuki</surname> <given-names>M</given-names></name><name><surname>Aoki</surname> <given-names>J</given-names></name><name><surname>Arakawa</surname> <given-names>T</given-names></name><name><surname>Iida</surname> <given-names>J</given-names></name><name><surname>Imamura</surname> <given-names>K</given-names></name><name><surname>Itoh</surname> <given-names>M</given-names></name><name><surname>Kato</surname> <given-names>T</given-names></name><name><surname>Kawaji</surname> <given-names>H</given-names></name><name><surname>Kawagashira</surname> <given-names>N</given-names></name><name><surname>Kawashima</surname> <given-names>T</given-names></name><name><surname>Kojima</surname> <given-names>M</given-names></name><name><surname>Kondo</surname> <given-names>S</given-names></name><name><surname>Konno</surname> <given-names>H</given-names></name><name><surname>Nakano</surname> <given-names>K</given-names></name><name><surname>Ninomiya</surname> <given-names>N</given-names></name><name><surname>Nishio</surname> <given-names>T</given-names></name><name><surname>Okada</surname> <given-names>M</given-names></name><name><surname>Plessy</surname> <given-names>C</given-names></name><name><surname>Shibata</surname> <given-names>K</given-names></name><name><surname>Shiraki</surname> <given-names>T</given-names></name><name><surname>Suzuki</surname> <given-names>S</given-names></name><name><surname>Tagami</surname> <given-names>M</given-names></name><name><surname>Waki</surname> <given-names>K</given-names></name><name><surname>Watahiki</surname> <given-names>A</given-names></name><name><surname>Okamura-Oho</surname> <given-names>Y</given-names></name><name><surname>Suzuki</surname> <given-names>H</given-names></name><name><surname>Kawai</surname> <given-names>J</given-names></name><name><surname>Hayashizaki</surname> <given-names>Y</given-names></name><collab>FANTOM Consortium</collab><collab>RIKEN Genome Exploration Research Group and Genome Science Group (Genome Network Project Core Group)</collab></person-group><year iso-8601-date="2005">2005</year><article-title>The transcriptional landscape of the mammalian genome</article-title><source>Science</source><volume>309</volume><fpage>1559</fpage><lpage>1563</lpage><pub-id pub-id-type="doi">10.1126/science.1112014</pub-id><pub-id pub-id-type="pmid">16141072</pub-id></element-citation></ref><ref id="bib13"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Carpenter</surname> <given-names>S</given-names></name><name><surname>Aiello</surname> <given-names>D</given-names></name><name><surname>Atianand</surname> <given-names>MK</given-names></name><name><surname>Ricci</surname> <given-names>EP</given-names></name><name><surname>Gandhi</surname> <given-names>P</given-names></name><name><surname>Hall</surname> <given-names>LL</given-names></name><name><surname>Byron</surname> <given-names>M</given-names></name><name><surname>Monks</surname> <given-names>B</given-names></name><name><surname>Henry-Bezy</surname> <given-names>M</given-names></name><name><surname>Lawrence</surname> <given-names>JB</given-names></name><name><surname>O'Neill</surname> <given-names>LA</given-names></name><name><surname>Moore</surname> <given-names>MJ</given-names></name><name><surname>Caffrey</surname> <given-names>DR</given-names></name><name><surname>Fitzgerald</surname> <given-names>KA</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>A long noncoding RNA mediates both activation and repression of immune response genes</article-title><source>Science</source><volume>341</volume><fpage>789</fpage><lpage>792</lpage><pub-id pub-id-type="doi">10.1126/science.1240925</pub-id><pub-id pub-id-type="pmid">23907535</pub-id></element-citation></ref><ref id="bib14"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Carpenter</surname> <given-names>S</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Fitzgerald KA: cytokines and long noncoding RNAs</article-title><source>Cold Spring Harbor Perspectives in Biology</source><volume>10</volume><elocation-id>a028589</elocation-id><pub-id pub-id-type="doi">10.1101/cshperspect.a028589</pub-id></element-citation></ref><ref id="bib15"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Carvalho</surname> <given-names>BS</given-names></name><name><surname>Irizarry</surname> <given-names>RA</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>A framework for oligonucleotide microarray preprocessing</article-title><source>Bioinformatics</source><volume>26</volume><fpage>2363</fpage><lpage>2367</lpage><pub-id pub-id-type="doi">10.1093/bioinformatics/btq431</pub-id><pub-id pub-id-type="pmid">20688976</pub-id></element-citation></ref><ref id="bib16"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cecconi</surname> <given-names>M</given-names></name><name><surname>Evans</surname> <given-names>L</given-names></name><name><surname>Levy</surname> <given-names>M</given-names></name><name><surname>Rhodes</surname> <given-names>A</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Sepsis and septic shock</article-title><source>The Lancet</source><volume>392</volume><fpage>75</fpage><lpage>87</lpage><pub-id pub-id-type="doi">10.1016/S0140-6736(18)30696-2</pub-id><pub-id pub-id-type="pmid">29937192</pub-id></element-citation></ref><ref id="bib17"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cheng</surname> <given-names>SC</given-names></name><name><surname>Scicluna</surname> <given-names>BP</given-names></name><name><surname>Arts</surname> <given-names>RJ</given-names></name><name><surname>Gresnigt</surname> <given-names>MS</given-names></name><name><surname>Lachmandas</surname> <given-names>E</given-names></name><name><surname>Giamarellos-Bourboulis</surname> <given-names>EJ</given-names></name><name><surname>Kox</surname> <given-names>M</given-names></name><name><surname>Manjeri</surname> <given-names>GR</given-names></name><name><surname>Wagenaars</surname> <given-names>JA</given-names></name><name><surname>Cremer</surname> <given-names>OL</given-names></name><name><surname>Leentjens</surname> <given-names>J</given-names></name><name><surname>van der Meer</surname> <given-names>AJ</given-names></name><name><surname>van de Veerdonk</surname> <given-names>FL</given-names></name><name><surname>Bonten</surname> <given-names>MJ</given-names></name><name><surname>Schultz</surname> <given-names>MJ</given-names></name><name><surname>Willems</surname> <given-names>PH</given-names></name><name><surname>Pickkers</surname> <given-names>P</given-names></name><name><surname>Joosten</surname> <given-names>LA</given-names></name><name><surname>van der Poll</surname> <given-names>T</given-names></name><name><surname>Netea</surname> <given-names>MG</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Broad defects in the energy metabolism of leukocytes underlie immunoparalysis in Sepsis</article-title><source>Nature Immunology</source><volume>17</volume><fpage>406</fpage><lpage>413</lpage><pub-id pub-id-type="doi">10.1038/ni.3398</pub-id><pub-id pub-id-type="pmid">26950237</pub-id></element-citation></ref><ref id="bib18"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Davenport</surname> <given-names>EE</given-names></name><name><surname>Burnham</surname> <given-names>KL</given-names></name><name><surname>Radhakrishnan</surname> <given-names>J</given-names></name><name><surname>Humburg</surname> <given-names>P</given-names></name><name><surname>Hutton</surname> <given-names>P</given-names></name><name><surname>Mills</surname> <given-names>TC</given-names></name><name><surname>Rautanen</surname> <given-names>A</given-names></name><name><surname>Gordon</surname> <given-names>AC</given-names></name><name><surname>Garrard</surname> <given-names>C</given-names></name><name><surname>Hill</surname> <given-names>AV</given-names></name><name><surname>Hinds</surname> <given-names>CJ</given-names></name><name><surname>Knight</surname> <given-names>JC</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Genomic landscape of the individual host response and outcomes in Sepsis: a prospective cohort study</article-title><source>The Lancet Respiratory Medicine</source><volume>4</volume><fpage>259</fpage><lpage>271</lpage><pub-id pub-id-type="doi">10.1016/S2213-2600(16)00046-1</pub-id><pub-id pub-id-type="pmid">26917434</pub-id></element-citation></ref><ref id="bib19"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>de Vos</surname> <given-names>AF</given-names></name><name><surname>Pater</surname> <given-names>JM</given-names></name><name><surname>van den Pangaart</surname> <given-names>PS</given-names></name><name><surname>de Kruif</surname> <given-names>MD</given-names></name><name><surname>van 't Veer</surname> <given-names>C</given-names></name><name><surname>van der Poll</surname> <given-names>T</given-names></name></person-group><year iso-8601-date="2009">2009</year><article-title>In vivo lipopolysaccharide exposure of human blood leukocytes induces cross-tolerance to multiple TLR ligands</article-title><source>The Journal of Immunology</source><volume>183</volume><fpage>533</fpage><lpage>542</lpage><pub-id pub-id-type="doi">10.4049/jimmunol.0802189</pub-id><pub-id pub-id-type="pmid">19542464</pub-id></element-citation></ref><ref id="bib20"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Diederichs</surname> <given-names>S</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>The four dimensions of noncoding RNA conservation</article-title><source>Trends in Genetics</source><volume>30</volume><fpage>121</fpage><lpage>123</lpage><pub-id pub-id-type="doi">10.1016/j.tig.2014.01.004</pub-id><pub-id pub-id-type="pmid">24613441</pub-id></element-citation></ref><ref id="bib21"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dumeaux</surname> <given-names>V</given-names></name><name><surname>Olsen</surname> <given-names>KS</given-names></name><name><surname>Nuel</surname> <given-names>G</given-names></name><name><surname>Paulssen</surname> <given-names>RH</given-names></name><name><surname>Børresen-Dale</surname> <given-names>AL</given-names></name><name><surname>Lund</surname> <given-names>E</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>Deciphering normal blood gene expression variation--the NOWAC postgenome study</article-title><source>PLOS Genetics</source><volume>6</volume><elocation-id>e1000873</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pgen.1000873</pub-id><pub-id pub-id-type="pmid">20300640</pub-id></element-citation></ref><ref id="bib22"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dunning</surname> <given-names>J</given-names></name><name><surname>Blankley</surname> <given-names>S</given-names></name><name><surname>Hoang</surname> <given-names>LT</given-names></name><name><surname>Cox</surname> <given-names>M</given-names></name><name><surname>Graham</surname> <given-names>CM</given-names></name><name><surname>James</surname> <given-names>PL</given-names></name><name><surname>Bloom</surname> <given-names>CI</given-names></name><name><surname>Chaussabel</surname> <given-names>D</given-names></name><name><surname>Banchereau</surname> <given-names>J</given-names></name><name><surname>Brett</surname> <given-names>SJ</given-names></name><name><surname>Moffatt</surname> <given-names>MF</given-names></name><name><surname>O'Garra</surname> <given-names>A</given-names></name><name><surname>Openshaw</surname> <given-names>PJM</given-names></name><collab>MOSAIC Investigators</collab></person-group><year iso-8601-date="2018">2018</year><article-title>Progression of whole-blood transcriptional signatures from interferon-induced to neutrophil-associated patterns in severe influenza</article-title><source>Nature Immunology</source><volume>19</volume><fpage>625</fpage><lpage>635</lpage><pub-id pub-id-type="doi">10.1038/s41590-018-0111-5</pub-id><pub-id pub-id-type="pmid">29777224</pub-id></element-citation></ref><ref id="bib23"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dweep</surname> <given-names>H</given-names></name><name><surname>Sticht</surname> <given-names>C</given-names></name><name><surname>Pandey</surname> <given-names>P</given-names></name><name><surname>Gretz</surname> <given-names>N</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>miRWalk--database: prediction of possible miRNA binding sites by &quot;walking&quot; the genes of three genomes</article-title><source>Journal of Biomedical Informatics</source><volume>44</volume><fpage>839</fpage><lpage>847</lpage><pub-id pub-id-type="doi">10.1016/j.jbi.2011.05.002</pub-id><pub-id pub-id-type="pmid">21605702</pub-id></element-citation></ref><ref id="bib24"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Esteller</surname> <given-names>M</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>Non-coding RNAs in human disease</article-title><source>Nature Reviews Genetics</source><volume>12</volume><fpage>861</fpage><lpage>874</lpage><pub-id pub-id-type="doi">10.1038/nrg3074</pub-id><pub-id pub-id-type="pmid">22094949</pub-id></element-citation></ref><ref id="bib25"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Figueiredo</surname> <given-names>N</given-names></name><name><surname>Chora</surname> <given-names>A</given-names></name><name><surname>Raquel</surname> <given-names>H</given-names></name><name><surname>Pejanovic</surname> <given-names>N</given-names></name><name><surname>Pereira</surname> <given-names>P</given-names></name><name><surname>Hartleben</surname> <given-names>B</given-names></name><name><surname>Neves-Costa</surname> <given-names>A</given-names></name><name><surname>Moita</surname> <given-names>C</given-names></name><name><surname>Pedroso</surname> <given-names>D</given-names></name><name><surname>Pinto</surname> <given-names>A</given-names></name><name><surname>Marques</surname> <given-names>S</given-names></name><name><surname>Faridi</surname> <given-names>H</given-names></name><name><surname>Costa</surname> <given-names>P</given-names></name><name><surname>Gozzelino</surname> <given-names>R</given-names></name><name><surname>Zhao</surname> <given-names>JL</given-names></name><name><surname>Soares</surname> <given-names>MP</given-names></name><name><surname>Gama-Carvalho</surname> <given-names>M</given-names></name><name><surname>Martinez</surname> <given-names>J</given-names></name><name><surname>Zhang</surname> <given-names>Q</given-names></name><name><surname>Döring</surname> <given-names>G</given-names></name><name><surname>Grompe</surname> <given-names>M</given-names></name><name><surname>Simas</surname> <given-names>JP</given-names></name><name><surname>Huber</surname> <given-names>TB</given-names></name><name><surname>Baltimore</surname> <given-names>D</given-names></name><name><surname>Gupta</surname> <given-names>V</given-names></name><name><surname>Green</surname> <given-names>DR</given-names></name><name><surname>Ferreira</surname> <given-names>JA</given-names></name><name><surname>Moita</surname> <given-names>LF</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Anthracyclines induce DNA damage response-mediated protection against severe Sepsis</article-title><source>Immunity</source><volume>39</volume><fpage>874</fpage><lpage>884</lpage><pub-id pub-id-type="doi">10.1016/j.immuni.2013.08.039</pub-id><pub-id pub-id-type="pmid">24184056</pub-id></element-citation></ref><ref id="bib26"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fitzgerald</surname> <given-names>KA</given-names></name><name><surname>Caffrey</surname> <given-names>DR</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Long noncoding RNAs in innate and adaptive immunity</article-title><source>Current Opinion in Immunology</source><volume>26</volume><fpage>140</fpage><lpage>146</lpage><pub-id pub-id-type="doi">10.1016/j.coi.2013.12.001</pub-id><pub-id pub-id-type="pmid">24556411</pub-id></element-citation></ref><ref id="bib27"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fleischmann</surname> <given-names>C</given-names></name><name><surname>Scherag</surname> <given-names>A</given-names></name><name><surname>Adhikari</surname> <given-names>NK</given-names></name><name><surname>Hartog</surname> <given-names>CS</given-names></name><name><surname>Tsaganos</surname> <given-names>T</given-names></name><name><surname>Schlattmann</surname> <given-names>P</given-names></name><name><surname>Angus</surname> <given-names>DC</given-names></name><name><surname>Reinhart</surname> <given-names>K</given-names></name><collab>International Forum of Acute Care Trialists</collab></person-group><year iso-8601-date="2016">2016</year><article-title>Assessment of global incidence and mortality of Hospital-treated Sepsis current estimates and limitations</article-title><source>American Journal of Respiratory and Critical Care Medicine</source><volume>193</volume><fpage>259</fpage><lpage>272</lpage><pub-id pub-id-type="doi">10.1164/rccm.201504-0781OC</pub-id><pub-id pub-id-type="pmid">26414292</pub-id></element-citation></ref><ref id="bib28"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gebert</surname> <given-names>LFR</given-names></name><name><surname>MacRae</surname> <given-names>IJ</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Regulation of microRNA function in animals</article-title><source>Nature Reviews Molecular Cell Biology</source><volume>20</volume><fpage>21</fpage><lpage>37</lpage><pub-id pub-id-type="doi">10.1038/s41580-018-0045-7</pub-id></element-citation></ref><ref id="bib29"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hoffman</surname> <given-names>GE</given-names></name><name><surname>Schadt</surname> <given-names>EE</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>variancePartition: interpreting drivers of variation in complex gene expression studies</article-title><source>BMC Bioinformatics</source><volume>17</volume><elocation-id>483</elocation-id><pub-id pub-id-type="doi">10.1186/s12859-016-1323-z</pub-id><pub-id pub-id-type="pmid">27884101</pub-id></element-citation></ref><ref id="bib30"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hotchkiss</surname> <given-names>RS</given-names></name><name><surname>Monneret</surname> <given-names>G</given-names></name><name><surname>Payen</surname> <given-names>D</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Immunosuppression in Sepsis: a novel understanding of the disorder and a new therapeutic approach</article-title><source>The Lancet Infectious Diseases</source><volume>13</volume><fpage>260</fpage><lpage>268</lpage><pub-id pub-id-type="doi">10.1016/S1473-3099(13)70001-X</pub-id><pub-id pub-id-type="pmid">23427891</pub-id></element-citation></ref><ref id="bib31"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kang</surname> <given-names>N</given-names></name><name><surname>Koo</surname> <given-names>J</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>Olfactory receptors in non-chemosensory tissues</article-title><source>BMB Reports</source><volume>45</volume><fpage>612</fpage><lpage>622</lpage><pub-id pub-id-type="doi">10.5483/BMBRep.2012.45.11.232</pub-id><pub-id pub-id-type="pmid">23186999</pub-id></element-citation></ref><ref id="bib32"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kapranov</surname> <given-names>P</given-names></name><name><surname>Cawley</surname> <given-names>SE</given-names></name><name><surname>Drenkow</surname> <given-names>J</given-names></name><name><surname>Bekiranov</surname> <given-names>S</given-names></name><name><surname>Strausberg</surname> <given-names>RL</given-names></name><name><surname>Fodor</surname> <given-names>SP</given-names></name><name><surname>Gingeras</surname> <given-names>TR</given-names></name></person-group><year iso-8601-date="2002">2002</year><article-title>Large-scale transcriptional activity in chromosomes 21 and 22</article-title><source>Science</source><volume>296</volume><fpage>916</fpage><lpage>919</lpage><pub-id pub-id-type="doi">10.1126/science.1068597</pub-id><pub-id pub-id-type="pmid">11988577</pub-id></element-citation></ref><ref id="bib33"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kauffmann</surname> <given-names>A</given-names></name><name><surname>Gentleman</surname> <given-names>R</given-names></name><name><surname>Huber</surname> <given-names>W</given-names></name></person-group><year iso-8601-date="2009">2009</year><article-title>arrayQualityMetrics--a bioconductor package for quality assessment of microarray data</article-title><source>Bioinformatics</source><volume>25</volume><fpage>415</fpage><lpage>416</lpage><pub-id pub-id-type="doi">10.1093/bioinformatics/btn647</pub-id><pub-id pub-id-type="pmid">19106121</pub-id></element-citation></ref><ref id="bib34"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Klein Klouwenberg</surname> <given-names>PM</given-names></name><name><surname>Ong</surname> <given-names>DS</given-names></name><name><surname>Bos</surname> <given-names>LD</given-names></name><name><surname>de Beer</surname> <given-names>FM</given-names></name><name><surname>van Hooijdonk</surname> <given-names>RT</given-names></name><name><surname>Huson</surname> <given-names>MA</given-names></name><name><surname>Straat</surname> <given-names>M</given-names></name><name><surname>van Vught</surname> <given-names>LA</given-names></name><name><surname>Wieske</surname> <given-names>L</given-names></name><name><surname>Horn</surname> <given-names>J</given-names></name><name><surname>Schultz</surname> <given-names>MJ</given-names></name><name><surname>van der Poll</surname> <given-names>T</given-names></name><name><surname>Bonten</surname> <given-names>MJ</given-names></name><name><surname>Cremer</surname> <given-names>OL</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Interobserver agreement of centers for disease control and prevention criteria for classifying infections in critically ill patients</article-title><source>Critical Care Medicine</source><volume>41</volume><fpage>2373</fpage><lpage>2378</lpage><pub-id pub-id-type="doi">10.1097/CCM.0b013e3182923712</pub-id><pub-id pub-id-type="pmid">23921277</pub-id></element-citation></ref><ref id="bib35"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kornienko</surname> <given-names>AE</given-names></name><name><surname>Dotter</surname> <given-names>CP</given-names></name><name><surname>Guenzl</surname> <given-names>PM</given-names></name><name><surname>Gisslinger</surname> <given-names>H</given-names></name><name><surname>Gisslinger</surname> <given-names>B</given-names></name><name><surname>Cleary</surname> <given-names>C</given-names></name><name><surname>Kralovics</surname> <given-names>R</given-names></name><name><surname>Pauler</surname> <given-names>FM</given-names></name><name><surname>Barlow</surname> <given-names>DP</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Long non-coding RNAs display higher natural expression variation than protein-coding genes in healthy humans</article-title><source>Genome Biology</source><volume>17</volume><elocation-id>14</elocation-id><pub-id pub-id-type="doi">10.1186/s13059-016-0873-8</pub-id><pub-id pub-id-type="pmid">26821746</pub-id></element-citation></ref><ref id="bib36"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Langfelder</surname> <given-names>P</given-names></name><name><surname>Horvath</surname> <given-names>S</given-names></name></person-group><year iso-8601-date="2008">2008</year><article-title>WGCNA: an R package for weighted correlation network analysis</article-title><source>BMC Bioinformatics</source><volume>9</volume><elocation-id>559</elocation-id><pub-id pub-id-type="doi">10.1186/1471-2105-9-559</pub-id><pub-id pub-id-type="pmid">19114008</pub-id></element-citation></ref><ref id="bib37"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Langfelder</surname> <given-names>P</given-names></name><name><surname>Horvath</surname> <given-names>S</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>Fast <italic>R</italic> functions for robust correlations and hierarchical clustering</article-title><source>Journal of Statistical Software</source><volume>46</volume><elocation-id>i11</elocation-id><pub-id pub-id-type="pmid">23050260</pub-id></element-citation></ref><ref id="bib38"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Leek</surname> <given-names>JT</given-names></name><name><surname>Storey</surname> <given-names>JD</given-names></name></person-group><year iso-8601-date="2007">2007</year><article-title>Capturing heterogeneity in gene expression studies by surrogate variable analysis</article-title><source>PLOS Genetics</source><volume>3</volume><elocation-id>e30161</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pgen.0030161</pub-id></element-citation></ref><ref id="bib39"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname> <given-names>G</given-names></name><name><surname>Mattick</surname> <given-names>JS</given-names></name><name><surname>Taft</surname> <given-names>RJ</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>A meta-analysis of the genomic and transcriptomic composition of complex life</article-title><source>Cell Cycle</source><volume>12</volume><fpage>2061</fpage><lpage>2072</lpage><pub-id pub-id-type="doi">10.4161/cc.25134</pub-id><pub-id pub-id-type="pmid">23759593</pub-id></element-citation></ref><ref id="bib40"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lowry</surname> <given-names>SF</given-names></name></person-group><year iso-8601-date="2005">2005</year><article-title>Human endotoxemia: a model for mechanistic insight and therapeutic targeting</article-title><source>Shock</source><volume>24</volume><fpage>94</fpage><lpage>100</lpage><pub-id pub-id-type="doi">10.1097/01.shk.0000191340.23907.a1</pub-id><pub-id pub-id-type="pmid">16374380</pub-id></element-citation></ref><ref id="bib41"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Luan</surname> <given-names>F</given-names></name><name><surname>Chen</surname> <given-names>W</given-names></name><name><surname>Chen</surname> <given-names>M</given-names></name><name><surname>Yan</surname> <given-names>J</given-names></name><name><surname>Chen</surname> <given-names>H</given-names></name><name><surname>Yu</surname> <given-names>H</given-names></name><name><surname>Liu</surname> <given-names>T</given-names></name><name><surname>Mo</surname> <given-names>L</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>An autophagy-related long non-coding RNA signature for glioma</article-title><source>FEBS Open Bio</source><volume>9</volume><fpage>653</fpage><lpage>667</lpage><pub-id pub-id-type="doi">10.1002/2211-5463.12601</pub-id><pub-id pub-id-type="pmid">30984540</pub-id></element-citation></ref><ref id="bib42"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Marshall</surname> <given-names>JC</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Why have clinical trials in Sepsis failed?</article-title><source>Trends in Molecular Medicine</source><volume>20</volume><fpage>195</fpage><lpage>203</lpage><pub-id pub-id-type="doi">10.1016/j.molmed.2014.01.007</pub-id><pub-id pub-id-type="pmid">24581450</pub-id></element-citation></ref><ref id="bib43"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Maslove</surname> <given-names>DM</given-names></name><name><surname>Wong</surname> <given-names>HR</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Gene expression profiling in Sepsis: timing, tissue, and translational considerations</article-title><source>Trends in Molecular Medicine</source><volume>20</volume><fpage>204</fpage><lpage>213</lpage><pub-id pub-id-type="doi">10.1016/j.molmed.2014.01.006</pub-id><pub-id pub-id-type="pmid">24548661</pub-id></element-citation></ref><ref id="bib44"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Maßberg</surname> <given-names>D</given-names></name><name><surname>Hatt</surname> <given-names>H</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Human olfactory receptors: novel cellular functions outside of the nose</article-title><source>Physiological Reviews</source><volume>98</volume><fpage>1739</fpage><lpage>1763</lpage><pub-id pub-id-type="doi">10.1152/physrev.00013.2017</pub-id><pub-id pub-id-type="pmid">29897292</pub-id></element-citation></ref><ref id="bib45"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mehta</surname> <given-names>A</given-names></name><name><surname>Baltimore</surname> <given-names>D</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>MicroRNAs as regulatory elements in immune system logic</article-title><source>Nature Reviews Immunology</source><volume>16</volume><fpage>279</fpage><lpage>294</lpage><pub-id pub-id-type="doi">10.1038/nri.2016.40</pub-id><pub-id pub-id-type="pmid">27121651</pub-id></element-citation></ref><ref id="bib46"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mills</surname> <given-names>JD</given-names></name><name><surname>Iyer</surname> <given-names>AM</given-names></name><name><surname>van Scheppingen</surname> <given-names>J</given-names></name><name><surname>Bongaarts</surname> <given-names>A</given-names></name><name><surname>Anink</surname> <given-names>JJ</given-names></name><name><surname>Janssen</surname> <given-names>B</given-names></name><name><surname>Zimmer</surname> <given-names>TS</given-names></name><name><surname>Spliet</surname> <given-names>WG</given-names></name><name><surname>van Rijen</surname> <given-names>PC</given-names></name><name><surname>Jansen</surname> <given-names>FE</given-names></name><name><surname>Feucht</surname> <given-names>M</given-names></name><name><surname>Hainfellner</surname> <given-names>JA</given-names></name><name><surname>Krsek</surname> <given-names>P</given-names></name><name><surname>Zamecnik</surname> <given-names>J</given-names></name><name><surname>Kotulska</surname> <given-names>K</given-names></name><name><surname>Jozwiak</surname> <given-names>S</given-names></name><name><surname>Jansen</surname> <given-names>A</given-names></name><name><surname>Lagae</surname> <given-names>L</given-names></name><name><surname>Curatolo</surname> <given-names>P</given-names></name><name><surname>Kwiatkowski</surname> <given-names>DJ</given-names></name><name><surname>Pasterkamp</surname> <given-names>RJ</given-names></name><name><surname>Senthilkumar</surname> <given-names>K</given-names></name><name><surname>von Oerthel</surname> <given-names>L</given-names></name><name><surname>Hoekman</surname> <given-names>MF</given-names></name><name><surname>Gorter</surname> <given-names>JA</given-names></name><name><surname>Crino</surname> <given-names>PB</given-names></name><name><surname>Mühlebner</surname> <given-names>A</given-names></name><name><surname>Scicluna</surname> <given-names>BP</given-names></name><name><surname>Aronica</surname> <given-names>E</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Coding and small non-coding transcriptional landscape of tuberous sclerosis complex cortical tubers: implications for pathophysiology and treatment</article-title><source>Scientific Reports</source><volume>7</volume><elocation-id>8089</elocation-id><pub-id pub-id-type="doi">10.1038/s41598-017-06145-8</pub-id><pub-id pub-id-type="pmid">28808237</pub-id></element-citation></ref><ref id="bib47"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Necsulea</surname> <given-names>A</given-names></name><name><surname>Kaessmann</surname> <given-names>H</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Evolutionary dynamics of coding and non-coding transcriptomes</article-title><source>Nature Reviews Genetics</source><volume>15</volume><fpage>734</fpage><lpage>748</lpage><pub-id pub-id-type="doi">10.1038/nrg3802</pub-id><pub-id pub-id-type="pmid">25297727</pub-id></element-citation></ref><ref id="bib48"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Perlee</surname> <given-names>D</given-names></name><name><surname>van Vught</surname> <given-names>LA</given-names></name><name><surname>Scicluna</surname> <given-names>BP</given-names></name><name><surname>Maag</surname> <given-names>A</given-names></name><name><surname>Lutter</surname> <given-names>R</given-names></name><name><surname>Kemper</surname> <given-names>EM</given-names></name><name><surname>van 't Veer</surname> <given-names>C</given-names></name><name><surname>Punchard</surname> <given-names>MA</given-names></name><name><surname>González</surname> <given-names>J</given-names></name><name><surname>Richard</surname> <given-names>MP</given-names></name><name><surname>Dalemans</surname> <given-names>W</given-names></name><name><surname>Lombardo</surname> <given-names>E</given-names></name><name><surname>de Vos</surname> <given-names>AF</given-names></name><name><surname>van der Poll</surname> <given-names>T</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Intravenous infusion of human adipose mesenchymal stem cells modifies the host response to lipopolysaccharide in humans: a randomized, Single-Blind, parallel group, placebo controlled trial</article-title><source>Stem Cells</source><volume>36</volume><fpage>1778</fpage><lpage>1788</lpage><pub-id pub-id-type="doi">10.1002/stem.2891</pub-id><pub-id pub-id-type="pmid">30063804</pub-id></element-citation></ref><ref id="bib49"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ponjavic</surname> <given-names>J</given-names></name><name><surname>Ponting</surname> <given-names>CP</given-names></name><name><surname>Lunter</surname> <given-names>G</given-names></name></person-group><year iso-8601-date="2007">2007</year><article-title>Functionality or transcriptional noise? evidence for selection within long noncoding RNAs</article-title><source>Genome Research</source><volume>17</volume><fpage>556</fpage><lpage>565</lpage><pub-id pub-id-type="doi">10.1101/gr.6036807</pub-id><pub-id pub-id-type="pmid">17387145</pub-id></element-citation></ref><ref id="bib50"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rohart</surname> <given-names>F</given-names></name><name><surname>Gautier</surname> <given-names>B</given-names></name><name><surname>Singh</surname> <given-names>A</given-names></name><name><surname>Lê Cao</surname> <given-names>KA</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>mixOmics: an R package for 'omics feature selection and multiple data integration</article-title><source>PLOS Computational Biology</source><volume>13</volume><elocation-id>e1005752</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pcbi.1005752</pub-id><pub-id pub-id-type="pmid">29099853</pub-id></element-citation></ref><ref id="bib51"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sartelli</surname> <given-names>M</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>A focus on intra-abdominal infections</article-title><source>World Journal of Emergency Surgery</source><volume>5</volume><elocation-id>9</elocation-id><pub-id pub-id-type="doi">10.1186/1749-7922-5-9</pub-id><pub-id pub-id-type="pmid">20302628</pub-id></element-citation></ref><ref id="bib52"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schadt</surname> <given-names>EE</given-names></name><name><surname>Monks</surname> <given-names>SA</given-names></name><name><surname>Drake</surname> <given-names>TA</given-names></name><name><surname>Lusis</surname> <given-names>AJ</given-names></name><name><surname>Che</surname> <given-names>N</given-names></name><name><surname>Colinayo</surname> <given-names>V</given-names></name><name><surname>Ruff</surname> <given-names>TG</given-names></name><name><surname>Milligan</surname> <given-names>SB</given-names></name><name><surname>Lamb</surname> <given-names>JR</given-names></name><name><surname>Cavet</surname> <given-names>G</given-names></name><name><surname>Linsley</surname> <given-names>PS</given-names></name><name><surname>Mao</surname> <given-names>M</given-names></name><name><surname>Stoughton</surname> <given-names>RB</given-names></name><name><surname>Friend</surname> <given-names>SH</given-names></name></person-group><year iso-8601-date="2003">2003</year><article-title>Genetics of gene expression surveyed in maize, mouse and man</article-title><source>Nature</source><volume>422</volume><fpage>297</fpage><lpage>302</lpage><pub-id pub-id-type="doi">10.1038/nature01434</pub-id><pub-id pub-id-type="pmid">12646919</pub-id></element-citation></ref><ref id="bib53"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schneider</surname> <given-names>DS</given-names></name><name><surname>Ayres</surname> <given-names>JS</given-names></name></person-group><year iso-8601-date="2008">2008</year><article-title>Two ways to survive infection: what resistance and tolerance can teach us about treating infectious diseases</article-title><source>Nature Reviews Immunology</source><volume>8</volume><fpage>889</fpage><lpage>895</lpage><pub-id pub-id-type="doi">10.1038/nri2432</pub-id><pub-id pub-id-type="pmid">18927577</pub-id></element-citation></ref><ref id="bib54"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Scicluna</surname> <given-names>BP</given-names></name><name><surname>van 't Veer</surname> <given-names>C</given-names></name><name><surname>Nieuwdorp</surname> <given-names>M</given-names></name><name><surname>Felsmann</surname> <given-names>K</given-names></name><name><surname>Wlotzka</surname> <given-names>B</given-names></name><name><surname>Stroes</surname> <given-names>ES</given-names></name><name><surname>van der Poll</surname> <given-names>T</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Role of tumor necrosis factor-α in the human systemic endotoxin-induced transcriptome</article-title><source>PLOS ONE</source><volume>8</volume><elocation-id>e79051</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pone.0079051</pub-id><pub-id pub-id-type="pmid">24236088</pub-id></element-citation></ref><ref id="bib55"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Scicluna</surname> <given-names>BP</given-names></name><name><surname>van Lieshout</surname> <given-names>MH</given-names></name><name><surname>Blok</surname> <given-names>DC</given-names></name><name><surname>Florquin</surname> <given-names>S</given-names></name><name><surname>van der Poll</surname> <given-names>T</given-names></name></person-group><year iso-8601-date="2015">2015a</year><article-title>Modular transcriptional networks of the host pulmonary response during early and late pneumococcal pneumonia</article-title><source>Molecular Medicine</source><volume>21</volume><fpage>430</fpage><lpage>441</lpage><pub-id pub-id-type="doi">10.2119/molmed.2014.00263</pub-id><pub-id pub-id-type="pmid">25998510</pub-id></element-citation></ref><ref id="bib56"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Scicluna</surname> <given-names>BP</given-names></name><name><surname>Klein Klouwenberg</surname> <given-names>PM</given-names></name><name><surname>van Vught</surname> <given-names>LA</given-names></name><name><surname>Wiewel</surname> <given-names>MA</given-names></name><name><surname>Ong</surname> <given-names>DS</given-names></name><name><surname>Zwinderman</surname> <given-names>AH</given-names></name><name><surname>Franitza</surname> <given-names>M</given-names></name><name><surname>Toliat</surname> <given-names>MR</given-names></name><name><surname>Nürnberg</surname> <given-names>P</given-names></name><name><surname>Hoogendijk</surname> <given-names>AJ</given-names></name><name><surname>Horn</surname> <given-names>J</given-names></name><name><surname>Cremer</surname> <given-names>OL</given-names></name><name><surname>Schultz</surname> <given-names>MJ</given-names></name><name><surname>Bonten</surname> <given-names>MJ</given-names></name><name><surname>van der Poll</surname> <given-names>T</given-names></name></person-group><year iso-8601-date="2015">2015b</year><article-title>A molecular biomarker to diagnose community-acquired pneumonia on intensive care unit admission</article-title><source>American Journal of Respiratory and Critical Care Medicine</source><volume>192</volume><fpage>826</fpage><lpage>835</lpage><pub-id pub-id-type="doi">10.1164/rccm.201502-0355OC</pub-id><pub-id pub-id-type="pmid">26121490</pub-id></element-citation></ref><ref id="bib57"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Scicluna</surname> <given-names>BP</given-names></name><name><surname>van Vught</surname> <given-names>LA</given-names></name><name><surname>Zwinderman</surname> <given-names>AH</given-names></name><name><surname>Wiewel</surname> <given-names>MA</given-names></name><name><surname>Davenport</surname> <given-names>EE</given-names></name><name><surname>Burnham</surname> <given-names>KL</given-names></name><name><surname>Nürnberg</surname> <given-names>P</given-names></name><name><surname>Schultz</surname> <given-names>MJ</given-names></name><name><surname>Horn</surname> <given-names>J</given-names></name><name><surname>Cremer</surname> <given-names>OL</given-names></name><name><surname>Bonten</surname> <given-names>MJ</given-names></name><name><surname>Hinds</surname> <given-names>CJ</given-names></name><name><surname>Wong</surname> <given-names>HR</given-names></name><name><surname>Knight</surname> <given-names>JC</given-names></name><name><surname>van der Poll</surname> <given-names>T</given-names></name><collab>MARS consortium</collab></person-group><year iso-8601-date="2017">2017</year><article-title>Classification of patients with Sepsis according to blood genomic endotype: a prospective cohort study</article-title><source>The Lancet Respiratory Medicine</source><volume>5</volume><fpage>816</fpage><lpage>826</lpage><pub-id pub-id-type="doi">10.1016/S2213-2600(17)30294-1</pub-id><pub-id pub-id-type="pmid">28864056</pub-id></element-citation></ref><ref id="bib58"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Seok</surname> <given-names>J</given-names></name><name><surname>Warren</surname> <given-names>HS</given-names></name><name><surname>Cuenca</surname> <given-names>AG</given-names></name><name><surname>Mindrinos</surname> <given-names>MN</given-names></name><name><surname>Baker</surname> <given-names>HV</given-names></name><name><surname>Xu</surname> <given-names>W</given-names></name><name><surname>Richards</surname> <given-names>DR</given-names></name><name><surname>McDonald-Smith</surname> <given-names>GP</given-names></name><name><surname>Gao</surname> <given-names>H</given-names></name><name><surname>Hennessy</surname> <given-names>L</given-names></name><name><surname>Finnerty</surname> <given-names>CC</given-names></name><name><surname>López</surname> <given-names>CM</given-names></name><name><surname>Honari</surname> <given-names>S</given-names></name><name><surname>Moore</surname> <given-names>EE</given-names></name><name><surname>Minei</surname> <given-names>JP</given-names></name><name><surname>Cuschieri</surname> <given-names>J</given-names></name><name><surname>Bankey</surname> <given-names>PE</given-names></name><name><surname>Johnson</surname> <given-names>JL</given-names></name><name><surname>Sperry</surname> <given-names>J</given-names></name><name><surname>Nathens</surname> <given-names>AB</given-names></name><name><surname>Billiar</surname> <given-names>TR</given-names></name><name><surname>West</surname> <given-names>MA</given-names></name><name><surname>Jeschke</surname> <given-names>MG</given-names></name><name><surname>Klein</surname> <given-names>MB</given-names></name><name><surname>Gamelli</surname> <given-names>RL</given-names></name><name><surname>Gibran</surname> <given-names>NS</given-names></name><name><surname>Brownstein</surname> <given-names>BH</given-names></name><name><surname>Miller-Graziano</surname> <given-names>C</given-names></name><name><surname>Calvano</surname> <given-names>SE</given-names></name><name><surname>Mason</surname> <given-names>PH</given-names></name><name><surname>Cobb</surname> <given-names>JP</given-names></name><name><surname>Rahme</surname> <given-names>LG</given-names></name><name><surname>Lowry</surname> <given-names>SF</given-names></name><name><surname>Maier</surname> <given-names>RV</given-names></name><name><surname>Moldawer</surname> <given-names>LL</given-names></name><name><surname>Herndon</surname> <given-names>DN</given-names></name><name><surname>Davis</surname> <given-names>RW</given-names></name><name><surname>Xiao</surname> <given-names>W</given-names></name><name><surname>Tompkins</surname> <given-names>RG</given-names></name><collab>Inflammation and Host Response to Injury, Large Scale Collaborative Research Program</collab></person-group><year iso-8601-date="2013">2013</year><article-title>Genomic responses in mouse models poorly mimic human inflammatory diseases</article-title><source>PNAS</source><volume>110</volume><fpage>3507</fpage><lpage>3512</lpage><pub-id pub-id-type="doi">10.1073/pnas.1222878110</pub-id><pub-id pub-id-type="pmid">23401516</pub-id></element-citation></ref><ref id="bib59"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Singer</surname> <given-names>M</given-names></name><name><surname>Deutschman</surname> <given-names>CS</given-names></name><name><surname>Seymour</surname> <given-names>CW</given-names></name><name><surname>Shankar-Hari</surname> <given-names>M</given-names></name><name><surname>Annane</surname> <given-names>D</given-names></name><name><surname>Bauer</surname> <given-names>M</given-names></name><name><surname>Bellomo</surname> <given-names>R</given-names></name><name><surname>Bernard</surname> <given-names>GR</given-names></name><name><surname>Chiche</surname> <given-names>JD</given-names></name><name><surname>Coopersmith</surname> <given-names>CM</given-names></name><name><surname>Hotchkiss</surname> <given-names>RS</given-names></name><name><surname>Levy</surname> <given-names>MM</given-names></name><name><surname>Marshall</surname> <given-names>JC</given-names></name><name><surname>Martin</surname> <given-names>GS</given-names></name><name><surname>Opal</surname> <given-names>SM</given-names></name><name><surname>Rubenfeld</surname> <given-names>GD</given-names></name><name><surname>van der Poll</surname> <given-names>T</given-names></name><name><surname>Vincent</surname> <given-names>JL</given-names></name><name><surname>Angus</surname> <given-names>DC</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>The third international consensus definitions for Sepsis and septic shock (Sepsis-3)</article-title><source>Jama</source><volume>315</volume><fpage>801</fpage><lpage>810</lpage><pub-id pub-id-type="doi">10.1001/jama.2016.0287</pub-id><pub-id pub-id-type="pmid">26903338</pub-id></element-citation></ref><ref id="bib60"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Smedley</surname> <given-names>D</given-names></name><name><surname>Haider</surname> <given-names>S</given-names></name><name><surname>Durinck</surname> <given-names>S</given-names></name><name><surname>Pandini</surname> <given-names>L</given-names></name><name><surname>Provero</surname> <given-names>P</given-names></name><name><surname>Allen</surname> <given-names>J</given-names></name><name><surname>Arnaiz</surname> <given-names>O</given-names></name><name><surname>Awedh</surname> <given-names>MH</given-names></name><name><surname>Baldock</surname> <given-names>R</given-names></name><name><surname>Barbiera</surname> <given-names>G</given-names></name><name><surname>Bardou</surname> <given-names>P</given-names></name><name><surname>Beck</surname> <given-names>T</given-names></name><name><surname>Blake</surname> <given-names>A</given-names></name><name><surname>Bonierbale</surname> <given-names>M</given-names></name><name><surname>Brookes</surname> <given-names>AJ</given-names></name><name><surname>Bucci</surname> <given-names>G</given-names></name><name><surname>Buetti</surname> <given-names>I</given-names></name><name><surname>Burge</surname> <given-names>S</given-names></name><name><surname>Cabau</surname> <given-names>C</given-names></name><name><surname>Carlson</surname> <given-names>JW</given-names></name><name><surname>Chelala</surname> <given-names>C</given-names></name><name><surname>Chrysostomou</surname> <given-names>C</given-names></name><name><surname>Cittaro</surname> <given-names>D</given-names></name><name><surname>Collin</surname> <given-names>O</given-names></name><name><surname>Cordova</surname> <given-names>R</given-names></name><name><surname>Cutts</surname> <given-names>RJ</given-names></name><name><surname>Dassi</surname> <given-names>E</given-names></name><name><surname>Di Genova</surname> <given-names>A</given-names></name><name><surname>Djari</surname> <given-names>A</given-names></name><name><surname>Esposito</surname> <given-names>A</given-names></name><name><surname>Estrella</surname> <given-names>H</given-names></name><name><surname>Eyras</surname> <given-names>E</given-names></name><name><surname>Fernandez-Banet</surname> <given-names>J</given-names></name><name><surname>Forbes</surname> <given-names>S</given-names></name><name><surname>Free</surname> <given-names>RC</given-names></name><name><surname>Fujisawa</surname> <given-names>T</given-names></name><name><surname>Gadaleta</surname> <given-names>E</given-names></name><name><surname>Garcia-Manteiga</surname> <given-names>JM</given-names></name><name><surname>Goodstein</surname> <given-names>D</given-names></name><name><surname>Gray</surname> <given-names>K</given-names></name><name><surname>Guerra-Assunção</surname> <given-names>JA</given-names></name><name><surname>Haggarty</surname> <given-names>B</given-names></name><name><surname>Han</surname> <given-names>DJ</given-names></name><name><surname>Han</surname> <given-names>BW</given-names></name><name><surname>Harris</surname> <given-names>T</given-names></name><name><surname>Harshbarger</surname> <given-names>J</given-names></name><name><surname>Hastings</surname> <given-names>RK</given-names></name><name><surname>Hayes</surname> <given-names>RD</given-names></name><name><surname>Hoede</surname> <given-names>C</given-names></name><name><surname>Hu</surname> <given-names>S</given-names></name><name><surname>Hu</surname> <given-names>ZL</given-names></name><name><surname>Hutchins</surname> <given-names>L</given-names></name><name><surname>Kan</surname> <given-names>Z</given-names></name><name><surname>Kawaji</surname> <given-names>H</given-names></name><name><surname>Keliet</surname> <given-names>A</given-names></name><name><surname>Kerhornou</surname> <given-names>A</given-names></name><name><surname>Kim</surname> <given-names>S</given-names></name><name><surname>Kinsella</surname> <given-names>R</given-names></name><name><surname>Klopp</surname> <given-names>C</given-names></name><name><surname>Kong</surname> <given-names>L</given-names></name><name><surname>Lawson</surname> <given-names>D</given-names></name><name><surname>Lazarevic</surname> <given-names>D</given-names></name><name><surname>Lee</surname> <given-names>JH</given-names></name><name><surname>Letellier</surname> <given-names>T</given-names></name><name><surname>Li</surname> <given-names>CY</given-names></name><name><surname>Lio</surname> <given-names>P</given-names></name><name><surname>Liu</surname> <given-names>CJ</given-names></name><name><surname>Luo</surname> <given-names>J</given-names></name><name><surname>Maass</surname> <given-names>A</given-names></name><name><surname>Mariette</surname> <given-names>J</given-names></name><name><surname>Maurel</surname> <given-names>T</given-names></name><name><surname>Merella</surname> <given-names>S</given-names></name><name><surname>Mohamed</surname> <given-names>AM</given-names></name><name><surname>Moreews</surname> <given-names>F</given-names></name><name><surname>Nabihoudine</surname> <given-names>I</given-names></name><name><surname>Ndegwa</surname> <given-names>N</given-names></name><name><surname>Noirot</surname> <given-names>C</given-names></name><name><surname>Perez-Llamas</surname> <given-names>C</given-names></name><name><surname>Primig</surname> <given-names>M</given-names></name><name><surname>Quattrone</surname> <given-names>A</given-names></name><name><surname>Quesneville</surname> <given-names>H</given-names></name><name><surname>Rambaldi</surname> <given-names>D</given-names></name><name><surname>Reecy</surname> <given-names>J</given-names></name><name><surname>Riba</surname> <given-names>M</given-names></name><name><surname>Rosanoff</surname> <given-names>S</given-names></name><name><surname>Saddiq</surname> <given-names>AA</given-names></name><name><surname>Salas</surname> <given-names>E</given-names></name><name><surname>Sallou</surname> <given-names>O</given-names></name><name><surname>Shepherd</surname> <given-names>R</given-names></name><name><surname>Simon</surname> <given-names>R</given-names></name><name><surname>Sperling</surname> <given-names>L</given-names></name><name><surname>Spooner</surname> <given-names>W</given-names></name><name><surname>Staines</surname> <given-names>DM</given-names></name><name><surname>Steinbach</surname> <given-names>D</given-names></name><name><surname>Stone</surname> <given-names>K</given-names></name><name><surname>Stupka</surname> <given-names>E</given-names></name><name><surname>Teague</surname> <given-names>JW</given-names></name><name><surname>Dayem Ullah</surname> <given-names>AZ</given-names></name><name><surname>Wang</surname> <given-names>J</given-names></name><name><surname>Ware</surname> <given-names>D</given-names></name><name><surname>Wong-Erasmus</surname> <given-names>M</given-names></name><name><surname>Youens-Clark</surname> <given-names>K</given-names></name><name><surname>Zadissa</surname> <given-names>A</given-names></name><name><surname>Zhang</surname> <given-names>SJ</given-names></name><name><surname>Kasprzyk</surname> <given-names>A</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>The BioMart community portal: an innovative alternative to large, centralized data repositories</article-title><source>Nucleic Acids Research</source><volume>43</volume><fpage>W589</fpage><lpage>W598</lpage><pub-id pub-id-type="doi">10.1093/nar/gkv350</pub-id><pub-id pub-id-type="pmid">25897122</pub-id></element-citation></ref><ref id="bib61"><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Smyth</surname> <given-names>GK</given-names></name></person-group><year iso-8601-date="2005">2005</year><chapter-title>Limma: linear models for microarray data</chapter-title><person-group person-group-type="editor"><name><surname>VJ C</surname> <given-names>H. W</given-names></name><name><surname>RA I</surname> <given-names>S. D</given-names></name></person-group><source>Bioinformatics and Computational Biology Solutions Using R</source><publisher-name>Springer</publisher-name><fpage>397</fpage><lpage>420</lpage></element-citation></ref><ref id="bib62"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Takao</surname> <given-names>K</given-names></name><name><surname>Miyakawa</surname> <given-names>T</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Genomic responses in mouse models greatly mimic human inflammatory diseases</article-title><source>PNAS</source><volume>112</volume><fpage>1167</fpage><lpage>1172</lpage><pub-id pub-id-type="doi">10.1073/pnas.1401965111</pub-id><pub-id pub-id-type="pmid">25092317</pub-id></element-citation></ref><ref id="bib63"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tani</surname> <given-names>H</given-names></name><name><surname>Onuma</surname> <given-names>Y</given-names></name><name><surname>Ito</surname> <given-names>Y</given-names></name><name><surname>Torimura</surname> <given-names>M</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Long non-coding RNAs as surrogate indicators for chemical stress responses in human-induced pluripotent stem cells</article-title><source>PLOS ONE</source><volume>9</volume><elocation-id>e106282</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pone.0106282</pub-id><pub-id pub-id-type="pmid">25171338</pub-id></element-citation></ref><ref id="bib64"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tse</surname> <given-names>MT</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Trial watch: sepsis study failure highlights need for trial design rethink</article-title><source>Nature Reviews Drug Discovery</source><volume>12</volume><elocation-id>334</elocation-id><pub-id pub-id-type="doi">10.1038/nrd4016</pub-id><pub-id pub-id-type="pmid">23629495</pub-id></element-citation></ref><ref id="bib65"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>van der Poll</surname> <given-names>T</given-names></name><name><surname>van de Veerdonk</surname> <given-names>FL</given-names></name><name><surname>Scicluna</surname> <given-names>BP</given-names></name><name><surname>Netea</surname> <given-names>MG</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>The immunopathology of Sepsis and potential therapeutic targets</article-title><source>Nature Reviews Immunology</source><volume>17</volume><fpage>407</fpage><lpage>420</lpage><pub-id pub-id-type="doi">10.1038/nri.2017.36</pub-id><pub-id pub-id-type="pmid">28436424</pub-id></element-citation></ref><ref id="bib66"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>van Vught</surname> <given-names>LA</given-names></name><name><surname>Klein Klouwenberg</surname> <given-names>PM</given-names></name><name><surname>Spitoni</surname> <given-names>C</given-names></name><name><surname>Scicluna</surname> <given-names>BP</given-names></name><name><surname>Wiewel</surname> <given-names>MA</given-names></name><name><surname>Horn</surname> <given-names>J</given-names></name><name><surname>Schultz</surname> <given-names>MJ</given-names></name><name><surname>Nürnberg</surname> <given-names>P</given-names></name><name><surname>Bonten</surname> <given-names>MJ</given-names></name><name><surname>Cremer</surname> <given-names>OL</given-names></name><name><surname>van der Poll</surname> <given-names>T</given-names></name><collab>MARS Consortium</collab></person-group><year iso-8601-date="2016">2016a</year><article-title>Incidence, risk factors, and attributable mortality of secondary infections in the intensive care unit after admission for Sepsis</article-title><source>Jama</source><volume>315</volume><fpage>1469</fpage><lpage>1479</lpage><pub-id pub-id-type="doi">10.1001/jama.2016.2691</pub-id><pub-id pub-id-type="pmid">26975785</pub-id></element-citation></ref><ref id="bib67"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>van Vught</surname> <given-names>LA</given-names></name><name><surname>Scicluna</surname> <given-names>BP</given-names></name><name><surname>Wiewel</surname> <given-names>MA</given-names></name><name><surname>Hoogendijk</surname> <given-names>AJ</given-names></name><name><surname>Klein Klouwenberg</surname> <given-names>PM</given-names></name><name><surname>Franitza</surname> <given-names>M</given-names></name><name><surname>Toliat</surname> <given-names>MR</given-names></name><name><surname>Nürnberg</surname> <given-names>P</given-names></name><name><surname>Cremer</surname> <given-names>OL</given-names></name><name><surname>Horn</surname> <given-names>J</given-names></name><name><surname>Schultz</surname> <given-names>MJ</given-names></name><name><surname>Bonten</surname> <given-names>MM</given-names></name><name><surname>van der Poll</surname> <given-names>T</given-names></name></person-group><year iso-8601-date="2016">2016b</year><article-title>Comparative analysis of the host response to Community-acquired and Hospital-acquired pneumonia in critically ill patients</article-title><source>American Journal of Respiratory and Critical Care Medicine</source><volume>194</volume><fpage>1366</fpage><lpage>1374</lpage><pub-id pub-id-type="doi">10.1164/rccm.201602-0368OC</pub-id><pub-id pub-id-type="pmid">27267747</pub-id></element-citation></ref><ref id="bib68"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vincent</surname> <given-names>J-L</given-names></name><name><surname>Moreno</surname> <given-names>R</given-names></name><name><surname>Takala</surname> <given-names>J</given-names></name><name><surname>Willatts</surname> <given-names>S</given-names></name><name><surname>De Mendonça</surname> <given-names>A</given-names></name><name><surname>Bruining</surname> <given-names>H</given-names></name><name><surname>Reinhart</surname> <given-names>CK</given-names></name><name><surname>Suter</surname> <given-names>PM</given-names></name><name><surname>Thijs</surname> <given-names>LG</given-names></name></person-group><year iso-8601-date="1996">1996</year><article-title>The SOFA (Sepsis-related organ Failure assessment) score to describe organ dysfunction/failure</article-title><source>Intensive Care Medicine</source><volume>22</volume><fpage>707</fpage><lpage>710</lpage><pub-id pub-id-type="doi">10.1007/BF01709751</pub-id></element-citation></ref><ref id="bib69"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wendlandt</surname> <given-names>EB</given-names></name><name><surname>Graff</surname> <given-names>JW</given-names></name><name><surname>Gioannini</surname> <given-names>TL</given-names></name><name><surname>McCaffrey</surname> <given-names>AP</given-names></name><name><surname>Wilson</surname> <given-names>ME</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>The role of microRNAs miR-200b and miR-200c in TLR4 signaling and NF-κB activation</article-title><source>Innate Immunity</source><volume>18</volume><fpage>846</fpage><lpage>855</lpage><pub-id pub-id-type="doi">10.1177/1753425912443903</pub-id><pub-id pub-id-type="pmid">22522429</pub-id></element-citation></ref><ref id="bib70"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wong</surname> <given-names>HR</given-names></name><name><surname>Cvijanovich</surname> <given-names>N</given-names></name><name><surname>Lin</surname> <given-names>R</given-names></name><name><surname>Allen</surname> <given-names>GL</given-names></name><name><surname>Thomas</surname> <given-names>NJ</given-names></name><name><surname>Willson</surname> <given-names>DF</given-names></name><name><surname>Freishtat</surname> <given-names>RJ</given-names></name><name><surname>Anas</surname> <given-names>N</given-names></name><name><surname>Meyer</surname> <given-names>K</given-names></name><name><surname>Checchia</surname> <given-names>PA</given-names></name><name><surname>Monaco</surname> <given-names>M</given-names></name><name><surname>Odom</surname> <given-names>K</given-names></name><name><surname>Shanley</surname> <given-names>TP</given-names></name></person-group><year iso-8601-date="2009">2009</year><article-title>Identification of pediatric septic shock subclasses based on genome-wide expression profiling</article-title><source>BMC Medicine</source><volume>7</volume><elocation-id>34</elocation-id><pub-id pub-id-type="doi">10.1186/1741-7015-7-34</pub-id><pub-id pub-id-type="pmid">19624809</pub-id></element-citation></ref><ref id="bib71"><element-citation publication-type="report"><person-group person-group-type="author"><collab>World Health Organization</collab></person-group><year iso-8601-date="2017">2017</year><source>Resolution WHA70.7: Improving the Prevention</source><publisher-name>Diagnosis and Clinical Management of Sepsis</publisher-name><ext-link ext-link-type="uri" xlink:href="https://www.who.int/servicedeliverysafety/areas/sepsis/en/">https://www.who.int/servicedeliverysafety/areas/sepsis/en/</ext-link></element-citation></ref><ref id="bib72"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Xiao</surname> <given-names>W</given-names></name><name><surname>Mindrinos</surname> <given-names>MN</given-names></name><name><surname>Seok</surname> <given-names>J</given-names></name><name><surname>Cuschieri</surname> <given-names>J</given-names></name><name><surname>Cuenca</surname> <given-names>AG</given-names></name><name><surname>Gao</surname> <given-names>H</given-names></name><name><surname>Hayden</surname> <given-names>DL</given-names></name><name><surname>Hennessy</surname> <given-names>L</given-names></name><name><surname>Moore</surname> <given-names>EE</given-names></name><name><surname>Minei</surname> <given-names>JP</given-names></name><name><surname>Bankey</surname> <given-names>PE</given-names></name><name><surname>Johnson</surname> <given-names>JL</given-names></name><name><surname>Sperry</surname> <given-names>J</given-names></name><name><surname>Nathens</surname> <given-names>AB</given-names></name><name><surname>Billiar</surname> <given-names>TR</given-names></name><name><surname>West</surname> <given-names>MA</given-names></name><name><surname>Brownstein</surname> <given-names>BH</given-names></name><name><surname>Mason</surname> <given-names>PH</given-names></name><name><surname>Baker</surname> <given-names>HV</given-names></name><name><surname>Finnerty</surname> <given-names>CC</given-names></name><name><surname>Jeschke</surname> <given-names>MG</given-names></name><name><surname>López</surname> <given-names>MC</given-names></name><name><surname>Klein</surname> <given-names>MB</given-names></name><name><surname>Gamelli</surname> <given-names>RL</given-names></name><name><surname>Gibran</surname> <given-names>NS</given-names></name><name><surname>Arnoldo</surname> <given-names>B</given-names></name><name><surname>Xu</surname> <given-names>W</given-names></name><name><surname>Zhang</surname> <given-names>Y</given-names></name><name><surname>Calvano</surname> <given-names>SE</given-names></name><name><surname>McDonald-Smith</surname> <given-names>GP</given-names></name><name><surname>Schoenfeld</surname> <given-names>DA</given-names></name><name><surname>Storey</surname> <given-names>JD</given-names></name><name><surname>Cobb</surname> <given-names>JP</given-names></name><name><surname>Warren</surname> <given-names>HS</given-names></name><name><surname>Moldawer</surname> <given-names>LL</given-names></name><name><surname>Herndon</surname> <given-names>DN</given-names></name><name><surname>Lowry</surname> <given-names>SF</given-names></name><name><surname>Maier</surname> <given-names>RV</given-names></name><name><surname>Davis</surname> <given-names>RW</given-names></name><name><surname>Tompkins</surname> <given-names>RG</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>A genomic storm in critically injured humans</article-title><source>Journal of Experimental Medicine</source><volume>208</volume><fpage>2581</fpage><lpage>2590</lpage><pub-id pub-id-type="doi">10.1084/jem.20111354</pub-id></element-citation></ref><ref id="bib73"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhao</surname> <given-names>W</given-names></name><name><surname>Langfelder</surname> <given-names>P</given-names></name><name><surname>Fuller</surname> <given-names>T</given-names></name><name><surname>Dong</surname> <given-names>J</given-names></name><name><surname>Li</surname> <given-names>A</given-names></name><name><surname>Hovarth</surname> <given-names>S</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>Weighted gene coexpression network analysis: state of the art</article-title><source>Journal of Biopharmaceutical Statistics</source><volume>20</volume><fpage>281</fpage><lpage>300</lpage><pub-id pub-id-type="doi">10.1080/10543400903572753</pub-id><pub-id pub-id-type="pmid">20309759</pub-id></element-citation></ref><ref id="bib74"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhu</surname> <given-names>S</given-names></name><name><surname>Li</surname> <given-names>W</given-names></name><name><surname>Liu</surname> <given-names>J</given-names></name><name><surname>Chen</surname> <given-names>CH</given-names></name><name><surname>Liao</surname> <given-names>Q</given-names></name><name><surname>Xu</surname> <given-names>P</given-names></name><name><surname>Xu</surname> <given-names>H</given-names></name><name><surname>Xiao</surname> <given-names>T</given-names></name><name><surname>Cao</surname> <given-names>Z</given-names></name><name><surname>Peng</surname> <given-names>J</given-names></name><name><surname>Yuan</surname> <given-names>P</given-names></name><name><surname>Brown</surname> <given-names>M</given-names></name><name><surname>Liu</surname> <given-names>XS</given-names></name><name><surname>Wei</surname> <given-names>W</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Genome-scale deletion screening of human long non-coding RNAs using a paired-guide RNA CRISPR-Cas9 library</article-title><source>Nature Biotechnology</source><volume>34</volume><fpage>1279</fpage><lpage>1286</lpage><pub-id pub-id-type="doi">10.1038/nbt.3715</pub-id><pub-id pub-id-type="pmid">27798563</pub-id></element-citation></ref><ref id="bib75"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zimmerman</surname> <given-names>JE</given-names></name><name><surname>Kramer</surname> <given-names>AA</given-names></name><name><surname>McNair</surname> <given-names>DS</given-names></name><name><surname>Malila</surname> <given-names>FM</given-names></name></person-group><year iso-8601-date="2006">2006</year><article-title>Acute physiology and chronic health evaluation (APACHE) IV: hospital mortality assessment for today's critically ill patients</article-title><source>Critical Care Medicine</source><volume>34</volume><fpage>1297</fpage><lpage>1310</lpage><pub-id pub-id-type="doi">10.1097/01.CCM.0000215112.84523.F0</pub-id><pub-id pub-id-type="pmid">16540951</pub-id></element-citation></ref></ref-list><app-group><app id="appendix-1"><title>Appendix 1</title><sec id="s8" sec-type="appendix"><title>Patients</title><boxed-text><p>Comorbidities were defined as follows: cardiovascular compromise was defined as a medical history of congestive heart failure, chronic cardiovascular disease, myocardial infarction, peripheral vascular disease, or cerebrovascular disease. Malignancy was defined as a medical history of either metastatic or not metastatic solid tumor, or hemodynamic malignancy. Patients with a history of chronic renal insufficiency or treated with chronic intermittent hemodialysis or continuous ambulatory peritoneal dialysis were marked as renal insufficient. Respiratory insufficiency included patients with a history of chronic respiratory insufficiency, chronic obstructive pulmonary disease, or treated at home with oxygen or ventilator support. Patients with a history of immune deficiency, human immunodeficiency virus (HIV) infection, acquired immune deficiency syndrome (AIDS), asplenia, or chronically treated with corticosteroids, antineoplastic or other immune suppressive medications were deemed immunocompromised.</p></boxed-text></sec></app></app-group></back><sub-article article-type="decision-letter" id="sa1"><front-stub><article-id pub-id-type="doi">10.7554/eLife.58597.sa1</article-id><title-group><article-title>Decision letter</article-title></title-group><contrib-group><contrib contrib-type="editor"><name><surname>Giamarellos-Bourboulis</surname><given-names>Evangelos J</given-names></name><role>Reviewing Editor</role><aff><institution>Attikon University Hospital</institution><country>Greece</country></aff></contrib></contrib-group><contrib-group><contrib contrib-type="reviewer"><name><surname>Giamarellos-Bourboulis</surname><given-names>Evangelos J</given-names></name><role>Reviewer</role><aff><institution>Attikon University Hospital</institution><country>Greece</country></aff></contrib><contrib contrib-type="reviewer"><name><surname>Bauer</surname><given-names>Michael</given-names> </name><role>Reviewer</role><aff><institution>Jena University Hospital</institution><country>Germany</country></aff></contrib></contrib-group></front-stub><body><boxed-text><p>In the interests of transparency, eLife publishes the most substantive revision requests and the accompanying author responses.</p></boxed-text><p><bold>Acceptance summary:</bold></p><p>Sepsis is a serious clinical condition, in which an abnormal host response to infection leads to organ failure with a high risk of death. This study by Scicluna et al. assesses the role of non-coding RNA in patients with sepsis. Using advanced molecular analysis and bioinformatics the authors compare non-coding RNA patterns in sepsis patients and healthy subjects. In addition, the authors have treated healthy volunteers with bacterial endotoxin, which is considered an important factor in bacterial sepsis, to investigate the role non-coding RNAs. They have found that long non-coding RNAs, and to a lesser extent small non-coding RNAs, were significantly altered in sepsis patients as compared to healthy controls. Thereby, this paper significantly adds to the current concepts of the regulatory responses in sepsis.</p><p><bold>Decision letter after peer review:</bold></p><p>Thank you for submitting your article &quot;The leukocyte non-coding RNA landscape in critically ill patients with sepsis&quot; for consideration by <italic>eLife</italic>. Your article has been reviewed by three peer reviewers, including Evangelos J Giamarellos-Bourboulis as the Reviewing Editor and Reviewer #1, and the evaluation has been overseen by Jos van der Meer as the Senior Editor. The following individual involved in review of your submission has agreed to reveal their identity: Michael Bauer (Reviewer #3).</p><p>The reviewers have discussed the reviews with one another and the Senior Editor has drafted this decision to help you prepare a revised submission.</p><p>We would like to draw your attention to changes in our revision policy that we have made in response to COVID-19 (https://elifesciences.org/articles/57162). Specifically, we are asking editors to accept without delay manuscripts, like yours, that they judge can stand as <italic>eLife</italic> papers without additional data, even if they feel that they would make the manuscript stronger. Thus the revisions requested below only address clarity and presentation.</p><p>Consensus review proposal:</p><p>Non-coding RNA have been recently discovered as a new component of regulatory complexity of gene Expression in eukaryotic cells. The present study by Scicluna et al. is aimed to assess the role of non-coding RNA in sepsis patients. Using advanced molecular analysis and bioinformatics the authors compare non-coding RNA patterns in sepsis patients and healthy subjects. Additional, healthy volunteers have been treated with lipopolysaccharide to investigate effects of endotoxemia on non-coding RNAs. Resulting data are of novelty and significantly add to the current knowledge on sepsis related regulatory responses. The RNA preparation and analysis has been accomplished by up-to-date technology.</p><p>The paper is descriptive, well-written, and with reasonable conclusions. It is a reasonable step forward in the field, but to some degree the paper suffers from a lack of context. Other authors have written on this topic and no attempt is made to discuss, reproduce, or bioinformatically include/compare to those studies.</p><p>Essential revisions:</p><p>1) The authors might consider PMID: 29657277 (data on GEO). A very small study is here: https://doi.org/10.1089/gtmb.2017.0061. They also might consider mining their own dataset GSE65682 as others have done recently: https://translational-medicine.biomedcentral.com/articles/10.1186/s12967-020-02372-2. Many microarrays measure lncRNAs and the data are available, just not examined, online. Shouldn't the authors try to validate their findings externally?</p><p>2) As a brief aside, much of the above is also true for endotoxin studies. There are also a huge number of studies looking at miRNAs in sepsis in a mechanistic fashion; nice review here: PMC6255943. All of this could be contextualized better.</p><p>3) Why is the analysis of non-coding RNAs in this submission accompanied by an analysis of protein-coding regions? We understand that the authors try to investigate how the expression of coding regions is modulated by non-coding regions in terms of pathways analysis, but the way data are analysed does not support such conclusions.</p><p>4) Although there is a positive association of coding-RNAs between sepsis patients and the LPS endotoxemia model, this is at the best marginal for the non-coding RNAs. This should be highlighted and the data of Figure 3—figure supplement 1 showing this should be moved in the core of the manuscript.</p><p>5) For Figure 1C and the resulting pathways analysis, was an effect size threshold also used? Or just significance?</p><p>6) Remarkable that the endotoxemia model had so few genes differently expressed from sepsis at 24 hours (just 43). Worth a comment on the model?</p><p>7) Across which data was the functional inference done? Sepsis only? Sepsis and healthy?</p><p>8) Figure 5 should be revised and demonstrate the correlation of biomarkers with non-coding RNAs.</p><p>9) Figure 5B examines shock vs. non-shock; can Figure 1 add this subclassification?</p><p>10) We welcome the authors to present Volcano plots and analysis of non-coding RNAs between survivors and non-survivors. Since data on 1-year survival are available, can the authors shifts in expression of non-coding RNAs between original after 28-days who become survivors and non-survivors after one year?</p><p>11) Materials and methods: do any patients profiled here overlap with this group's prior microarray studies?</p><p>12) Materials and methods: why were two different microarray types used, and how was this technical difference accounted for in the sepsis-vs.-endotoxemia analysis?</p><p>13) As the results indicating correlation of non-coding RNA profiles in sepsis patients and expression profiles in the human endotoxemia model simultaneously with endotoxin tolerance is of extraordinary importance and interest, we suggest discussion of the (accidental) interplay of resistance and tolerance responses during endoxemia and sepsis.</p></body></sub-article><sub-article article-type="reply" id="sa2"><front-stub><article-id pub-id-type="doi">10.7554/eLife.58597.sa2</article-id><title-group><article-title>Author response</article-title></title-group></front-stub><body><disp-quote content-type="editor-comment"><p>Essential revisions:</p><p>1) The authors might consider PMID: 29657277 (data on GEO). A very small study is here: https://doi.org/10.1089/gtmb.2017.0061. They also might consider mining their own dataset GSE65682 as others have done recently: https://translational-medicine.biomedcentral.com/articles/10.1186/s12967-020-02372-2. Many microarrays measure lncRNAs and the data are available, just not examined, online. Shouldn't the authors try to validate their findings externally?</p></disp-quote><p>Absolutely, we have certainly searched the public domain for independent datasets to provide a level of robustness to the patterns we observed. The three studies noted by the reviewers were indeed shortlisted in our search for potential use as external validation cohorts. However, we found certain issues with the studies that precluded their use in validation of our findings. The study by da Silva Pellegrini, et al. (PMID: 29657277) was done on a granulocyte fraction after Ficoll-Paque density gradient centrifugation of whole blood, that is, only polymorphonuclear cells were assessed. This contrasts tremendously with our study on whole blood leukocytes. The data used in the study by Dai, et al. (PMID: 28872921) is not available in the public domain, and severely underpowered since the authors performed microarray analysis of 3 septic patients relative to 3 healthy controls. The study by Cheng, et al. (PMID: 32471511), which also included our own previous data (not on non-coding RNA expression), was done by inferring the potential interaction of long non-coding RNA with coding gene expression profiles, that is, not one long non-coding RNA mentioned was measured. Thus, while of high interest, these earlier studies unfortunately cannot be used to validate our findings.</p><disp-quote content-type="editor-comment"><p>2) As a brief aside, much of the above is also true for endotoxin studies. There are also a huge number of studies looking at miRNAs in sepsis in a mechanistic fashion; nice review here: PMC6255943. All of this could be contextualized better.</p></disp-quote><p>We concur with the reviewers that a body of work has identified specific microRNA as potential modulators of the immune response, particularly endotoxin tolerance, as kindly noted by the reviewers in the article by Vergadi and colleagues (PMC6255943). However, interpretation of our findings in the context of previous studies on microRNA is complicated by the fact that the majority of clinical studies focused on extracellular (circulating) microRNA, whereas more mechanistic studies employed predominantly mouse macrophages or a pro-monocytic cell line THP1 or human embryonic kidney cell lines. In order to accommodate the reviewer’s suggestion, we opted to specifically discuss those miRNA that were unmasked as potential co-expression network modulators. We found that hsa-miR-200c (Figure 4E) was shown to modify the capacity of HEK293 cells for TLR-signaling in a MYD88-dependent fashion (see Wendlandt et al., 2012). We greatly appreciated the reviewers for raising this question as it has certainly helped in raising the confidence level of our network findings. The main text has been revised accordingly:</p><p>“Of note, hsa-miR-200c-3p has been shown to modify TLR4 signaling efficiency dependent on MYD88-mediated pathways in an embryonic kidney cell line (HEK293).(Wendlandt et al., 2012)”</p><disp-quote content-type="editor-comment"><p>3) Why is the analysis of non-coding RNAs in this submission accompanied by an analysis of protein-coding regions? We understand that the authors try to investigate how the expression of coding regions is modulated by non-coding regions in terms of pathways analysis, but the way data are analysed does not support such conclusions.</p></disp-quote><p>We analyzed protein-coding and non-coding RNA in combination because we sought to mainly infer on the functional connotations of long non-coding RNA. Functional inference of long non-coding RNA is currently limited to a handful of transcripts, unlike those of protein-coding RNA. To address this problem, we reasoned that by identifying modules (or clusters) of tightly correlating protein-coding and non-coding RNA we can then infer on functional outputs of non-coding RNA by virtue of the pathways that associate with protein-coding RNA in each module. Using this “guilt-by-association” approach we were able to position a substantial proportion of non-coding RNA with otherwise no known functional annotation. We discuss this aspect of our analysis in the Discussion section, while avoiding the topic of protein-coding RNA modulation by non-coding RNA since, as the reviewers rightly pointed out, the analytical strategy we undertook would not support it. To clarify this issue in the revised manuscript we modified the following section:</p><p>“To address this challenge, we undertook a guilt-by-association strategy that sought to position long non-coding RNA in co-expression modules of tightly correlating protein-coding RNA, thereby infer on functional outputs of long non-coding RNA by virtue of the pathways that associate with protein-coding RNA in each module.”</p><disp-quote content-type="editor-comment"><p>4) Although there is a positive association of coding-RNAs between sepsis patients and the LPS endotoxemia model, this is at the best marginal for the non-coding RNAs. This should be highlighted and the data of Figure 3—figure supplement 1 showing this should be moved in the core of the manuscript.</p></disp-quote><p>It is definitely remarkable that non-coding RNA expression in sepsis patients was marginally correlated to that in the human endotoxemia model. In particular, small non-coding RNA mainly showed indirect correlations. We agree with the reviewers to restructure Figure 3 by including data originally found in Figure 3—figure supplement 1. Specifically, we moved Figure 3—figure supplement 1E to Figure 3A, showing the extent of the correlation in protein-coding RNA expression between sepsis and endotoxemia.</p><disp-quote content-type="editor-comment"><p>5) For Figure 1C and the resulting pathways analysis, was an effect size threshold also used? Or just significance?</p></disp-quote><p>We used a fold change cutoff (≤ -1.2 or ≥ 1.2) and adjusted P-value ≤ 0.01. We included this information as a legend beneath volcano plots in Figure 1C. In addition, all other volcano plots throughout our manuscript were clarified by including legends for fold change cutoffs.</p><disp-quote content-type="editor-comment"><p>6) Remarkable that the endotoxemia model had so few genes differently expressed from sepsis at 24 hours (just 43). Worth a comment on the model?</p></disp-quote><p>Yes, definitely worth a comment and to accommodate the reviewer’s suggestion we have now expanded on the human endotoxemia model in the Discussion:</p><p>“The human endotoxemia model is a highly relevant in vivo model of acute systemic inflammation in the context of a controlled clinical setting (Lowry, 2005). In general, the model is characterized by a robust systemic response, including leukocyte transcriptional responses, exhibiting shared and unique temporal changes that resolve within 24 hours of bolus administration (Calvano et al., 2005; Perlee et al., 2018).”</p><disp-quote content-type="editor-comment"><p>7) Across which data was the functional inference done? Sepsis only? Sepsis and healthy?</p></disp-quote><p>Functional inference was done with sepsis patients only. We reasoned that in so doing we could test the co-expression modules against clinical characteristics, that is, without the confounding signal of the dramatic changes in sepsis relative to health. In order to clarify this point, we added the following to the main text:</p><p>“On the basis of a bi-weight midcorrelation matrix of the most variable protein-coding and long non-coding RNA (n=8539; coefficient of variation &gt; 5%) in sepsis patients only, …”</p><disp-quote content-type="editor-comment"><p>8) Figure 5 should be revised and demonstrate the correlation of biomarkers with non-coding RNAs.</p></disp-quote><p>To address this comment, we calculated the connectivity of each transcript (sum of transcript adjacencies with respect to other module transcripts) in the co-expression network as described in the Materials and methods and illustrated in Figure 4. By ranking the intra-module connectivities we identified non-coding RNA as module “hubs”. Correlation analysis of all “hub” non-coding RNA against soluble mediators showed strong correlations, particularly for markers of systemic inflammation. Of note, these patterns fully reflected the module eigengene correlations to soluble mediators shown in Figure 5A. To illustrate these findings, we focused our attention on modules that correlate substantially to levels of different soluble mediators, that is, neutrophil degranulation (red) and TLR signaling (black). Figure 5D and E now depict dot plots of <italic>MYOSLID</italic> (Myocardin-Induced Smooth Muscle LncRNA, Inducer Of Differentiation) expression (red module hub) and <italic>LUCAT1</italic> (Lung Cancer Associated Transcript 1) expression (black module hub), respectively, against levels of inflammatory response markers IL-6, IL-8, IL-10, and acute phase response protein CRP. <italic>MYOSLID</italic> expression correlated directly with inflammatory markers, whereas in contrast <italic>LUCAT1</italic> expression was indirectly correlated. We thank the reviewers for motivating this analysis as it has provided specificity to formulating testable hypotheses on the functions of non-coding RNA thereby strengthening our study. The Results section and figure legend have been revised as follows:</p><p>“LincRNA and antisense RNA included an inducer of differentiation <italic>MYOSLID</italic> (Myocardin-Induced Smooth Muscle LncRNA, Inducer Of Differentiation), cell proliferation and metastasis associated antisense RNA of the titin gene (TTN-AS1) and a IL10 receptor beta subunit antisense RNA, IL10RB-AS1. […] In contrast, <italic>LUCAT1</italic> expression was indirectly correlated to soluble mediators of inflammation, except for CRP (Figure 5E).”</p><p>Figure 5D and E legend: “(D and E) Dot plots of (D) <italic>MYOSLID</italic> expression and (E) <italic>LUCAT1</italic> expression against soluble mediators of inflammation IL-6, IL-8 and IL-10, as well as the acute phase response protein CRP. Rho, Spearman’s coefficient.”</p><disp-quote content-type="editor-comment"><p>9) Figure 5B examines shock vs. non-shock; can Figure 1 add this subclassification?</p></disp-quote><p>Definitely, and since the question is related to a source of transcriptomic variation in sepsis patients, we would prefer including the analysis motivated by the reviewer in Figure 2. Figure 2 illustrates an analysis of variance in blood transcriptomes of sepsis patients against various demographic and clinical characteristics, including shock. Figure 2C and D now depict the global blood transcriptomic changes in septic shock patients relative to no shock. In the Results section we have included the following sentences to report the new findings:</p><p>“Septic shock explained low proportions of variation in RNA expression (Figure 2A), and directly comparing patients with septic shock to patients without shock resulted in 837 and 80 significantly altered protein-coding and long non-coding RNA, respectively (Figure 2C). […] Low expression protein-coding RNA included a Na+/Ca<sup>2+</sup> exchanger (SLC8A1), membrane metalloendopeptidase (<italic>MME</italic>) and interleukin (IL-) 6 receptor (<italic>IL6R</italic>). Long non-coding RNA included lincRNA lung cancer associated transcript 1 (<italic>LUCAT1</italic>; low expression) and antisense RNA (<italic>LRRC75A-AS1</italic>; high expression) (Figure 2C). No significant alterations were identified in small non-coding RNA expression profiles.”</p><p>The legend of Figure 2 has also been revised to include the following details: “(C) Volcano plots depicting the changes in protein-coding and long non-coding RNA in patients discordant for septic shock on ICU admission. Horizontal (black) line denotes the adjusted p-value threshold for significance (adjusted p ≤ 0.01).”</p><disp-quote content-type="editor-comment"><p>10) We welcome the authors to present Volcano plots and analysis of non-coding RNAs between survivors and non-survivors. Since data on 1-year survival are available, can the authors shifts in expression of non-coding RNAs between original after 28-days who become survivors and non-survivors after one year?</p></disp-quote><p>Based on the reviewer’s comments, we firstly report results pertaining to long non-coding RNA expression in sepsis patients discordant for survival after 28 days of ICU admission. Secondly, considering only 28-day survivors we compared non-survivors to survivors after one year follow-up. We uncovered differences in protein-coding RNA profiles, albeit minimal, but no differences were observed for non-coding RNA profiles. This analysis suggests that non-coding RNA expression may not be a suitable source of signal for mortality prediction. No differences were found for 28-day survivors followed up to one year. Since our data showed no added value of RNA expression in discriminating sepsis survivors from non-survivors, we opted to only include a few sentences to report the results of the 28-day mortality analysis. However, if the reviewer would prefer us to incorporate the one year follow up analysis of 28-day survivors, we will gladly add them to the main text. The Results section was revised accordingly:</p><p>“Evaluating RNA expression in patients discordant for survival after 28 days, identified 146 significantly altered protein-coding RNA (Figure 2—figure supplement 2C). No significant differences were uncovered in non-coding RNA expression profiles, suggesting that non-coding RNA profiles obtained on ICU admission may not be suitable as mortality predictors.”</p><p>Figure 2—figure supplement 1 legend: “(C) Volcano plot of significantly altered protein-coding RNA in non-survivors relative to survivors after 28 days since ICU admission. Horizontal (black) line denotes -log10 transformed adjusted p-value thresholds.”</p><disp-quote content-type="editor-comment"><p>11) Materials and methods: do any patients profiled here overlap with this group's prior microarray studies?</p></disp-quote><p>None of the patients profiled here overlap with our previous microarray studies.</p><disp-quote content-type="editor-comment"><p>12) Materials and methods: why were two different microarray types used, and how was this technical difference accounted for in the sepsis-vs.-endotoxemia analysis?</p></disp-quote><p>Two types of arrays were used in all samples (sepsis patients and human endotoxemia) based on their specificity for measuring the different types of non-coding RNA expression. The human transcriptome array (HTA) 2.0 was designed for exon-level protein-coding RNA and mainly long non-coding RNA expression studies. The miRNA 4.1 array was used to comprehensively assay small non-coding RNA including types of small RNA (precursor miRNA, stem loop RNA, etc.) that are not covered in the HTA 2.0 microarrays. To clarify this we added the following to the Materials and methods section:</p><p>“Both arrays were done on all samples (sepsis patients, controls and healthy subjects injected with LPS)”.</p><disp-quote content-type="editor-comment"><p>13) As the results indicating correlation of non-coding RNA profiles in sepsis patients and expression profiles in the human endotoxemia model simultaneously with endotoxin tolerance is of extraordinary importance and interest, we suggest discussion of the (accidental) interplay of resistance and tolerance responses during endoxemia and sepsis.</p></disp-quote><p>In accordance with the suggestion of the reviewer we added the following to the Discussion:</p><p>“The host response during infection is characterized by a balance between resistance (seeking to limit the pathogen load) and tolerance (aiming to retain cell and organ functions)(Schneider and Ayres, 2008). […] While our time-sequential data in healthy humans injected with LPS suggest that coding and long non-coding RNA profiles in blood leukocytes of sepsis patients particularly reflect a tolerant state, time course studies in patients are needed to increase the insight into the role of distinct RNA species in the interplay between resistance and tolerance”.</p></body></sub-article></article>